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Abstract
Chemoattractant gradients play important roles in the normal function of immune system, from
lymphocyte homeostasis to mounting efficient immune responses against infection. Improved
fundamental knowledge about the role of chemoattractant gradients developed around single source cells
in controlling chemotaxis of "receiving" cells would not only greatly advance our understanding of the
basic mechanisms of cell chemotaxis but also would inform strategies for modulating chemoattractant
gradients in therapeutic applications, such as adjuvant materials for vaccines and cancer immunotherapy
recruiting immune cells of interest.
In this thesis, we first applied mathematical modeling to understand the key characteristics of
chemoattractant gradients secreted from single source cells at physiological rates. During the transport of
chemoattractants, we considered the diffusion of soluble attractants, binding to matrix and degradation by
proteolytic enzymes. From the calculated chemoattractant concentration gradients, we predicted the
characteristics of attractant receptor engagement on responding cells, and estimated the maximum
stimulation distance effectively triggering chemotaxis of responding cells based on the threshold for
receptor engagement gradients, a difference of -10 ligand-engaged receptors between the front and back
of responding cells. This characteristic maximum stimulation distance is a function of multiple
parameters including secretion rate of the source cell, diffusion constant of the chemoattractant,
interaction with matrix, degradation or clearance of chemoattractant in the tissues, and the density of
source cells. In addition, chemokine receptor desensitization induced by chemoattractants could shorten
the maximum stimulation distance.
We then developed Artificial Secreting Cells (ASCs) to mimic real chemoattractant secreting cells
using cell-sized polysaccharide-based hydrogel microspheres releasing chemoattractant in a controlled
manner. These alginate hydrogel microspheres, -30 ptm in size, were crosslinked with Ca" between
gluronic acid units on alginate backbones and provided a natural and bioactive environment for
chemokines. The chemokines could be loaded into these alginate microspheres by soaking them in
concentrated chemokine solutions and released in a reversible manner. This approach was shown as a
general strategy for several chemokines, such as CCL21, CCL19, CXCL10 and CXCL12. The loading
and release properties of individual chemokines were highly correlated with the average charge density on
protein surface. We have also demonstrated that the controlled gradients created by ASCs were similar to
the modeled gradients developed around single source cells.
Further we used 3D collagen hydrogels embedded with ASCs as an in vitro model to investigate
single human T-cell and dendritic cell migration dynamics to CCL21 and CCL19 chemokine gradients.
Individual T-cells exhibited a binary response to isolated attractant sources, migrating highly directionally
or ignoring the gradient completely; the fraction of responding cells correlated with chemokine receptor
occupancy induced by the gradient. In sustained gradients eliciting low receptor desensitization, attracted
T-cells or dendritic cells swarmed around isolated ASCs for hours. With increasing ASC density,
overlapping gradients and high attractant concentrations caused a transition from local swarming to
transient "hopping" of cells bead to bead. Thus, diverse migration responses observed in vivo may be
determined by chemoattractant source density and secretion rate, which govern receptor occupancy
patterns in nearby cells.
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Chapter 1 Introduction and background
1.1 Introduction
Lymphocyte trafficking is very important during the processes of development,
homeostasis and ongoing immune responses within primary lymphoid organs, secondary
lymphoid organs (SLO) and peripheral tissues [1-3]. The migration of lymphocytes is believed to
be directed and controlled by a series of chemotactic molecular signals, chemoattractants [2].
Chemoattractants are usually secreted by individual cells and then diffuse in the surrounding
tissue forming soluble and/or immobilized concentration gradients [4]. Lymphocytes with the
corresponding chemokine receptors are able to sense the concentration differences and migrate
up the gradient to the areas of high concentration of chemoattractants, a process called
chemotaxis [5]. A great amount of work has been done to explore this basic phenomenon for not
only lymphocytes, but also bacteria, fibroblasts, and neutrophils, etc. [5]. However, much of the
current understanding of chemotaxis is semi-quantitative in nature. How the quantitative
characteristics of chemokine gradients derived from individual cell as 'point' sources of
chemokine control the three dimensional (3D) navigation of lymphocytes through tissues
remains poorly defined.
Given the importance of chemoattractants in the function of the immune system and the
need of understanding how chemoattractant gradients control chemotaxis at the single-cell level,
it would be of great interest to be able to experimentally mimic the secretion patterns of single
cells, while having control over attractant release in a manner that is problematic to achieve with
live "source" cells. To address these challenges, in this thesis we developed synthetic cell-sized
polysaccharide hydrogel-based microsphere carriers with controlled release of chemoattractants
at tailored rates to engineer chemoattractant gradients. We employed these ASCs in a simple in
vitro system to allow us quantitatively investigate human T cell (and less exhaustively, dendritic
cell) migration to single local "point" sources of chemoattractants, as well as collections of
multiple point sources. This approach allowed us to examine human cell trafficking that is not
currently possible to observe and manipulate in vivo, and also provided useful information that
could be used to design artificial lymph nodes to screen drugs and vaccines, and these ASCs
have the potential to be used as adjuvant materials for vaccines and cancer immunotherapy.
1.2 Background
1.2.1 Leukocyte trafficking in the immune system
Distinct from mesenchymal and epithelial cells, leukocytes can exhibit rapid motility, up to
20-25 tm/min in 3D extracellular matrix (ECM) for neutrophils and lymphocytes [6]. They
scatter through the whole body, travelling between organs and circulating in the blood, with the
potential to infiltrate any tissue [7]. Leukocyte trafficking plays very important roles in the
normal functions of immune system. During the development of immune cells, precursors arise
from bone marrow stem cells, migrate to primary lymphoid organs or stay within the bone
marrow to mature, and finally move to the blood circulation or peripheral tissues [8]. During
homeostasis, immune cells are circulating in the blood or resident in peripheral tissues to
construct different layers of the immune system to protect against blood, skin or gut-borne
pathogens. In response to insults, immune cells respond to clear acute and chronic infections by
rapidly mounting both innate and adaptive immune responses.
We have focused on T lymphocyte migration in this thesis, so let's take different stages in
T-cell development and migration as an example, sketched in Figure 1.1 [8], to understand the
impact of leukocyte trafficking patterns in more detail. In the bone marrow, pluripotent stem
cells give rise to common lymphoid progenitors expressing IL-7R, and then these progenitor
cells migrate to the thymus, where they undergo a series of maturation events including somatic
recombination and expression of TCR genes, cell proliferation, antigen induced selection, and
acquisition of maturation phenotypes and functional capabilities [9].
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Figure 1.1 Schematic of lymphocyte trafficking during physiological and pathological states
in the human body 18].
NaYve T-cells circulate in the blood and search SLOs, such as lymph nodes (LN), spleen,
and Peyer's patches (PP) for cognate antigens. SLOs are strategically positioned in the body,
acting as a platform for mounting adaptive immune responses as well as maintaining homeostatic
environments for resting lymphocytes. The most distinct feature of LNs is T/B cell
compartmentalization within the organ, as shown in Figure 1.2. The T-cell zone is in the center
while B-cell follicles are arrayed at the periphery. NaYve T-cells enter LNs through high
endothelium venules (HEVs) and migrate to T zone, where they search through the antigen
presenting cell (APC) repertoire for cognate antigens.
T cell 1 B cell
Figure 1.2 T/B cell compartmentalization in lymph nodes as revealed by
immunohistochemical staining of a thin section of lymph node tissue [10].
In response to infection, an orchestrated series of events occurs to initiate the primary
immune response. Critically, APCs presenting antigens from infectious agents must meet rare
antigen specific T-cells in the lymph nodes to initiate the response. After an infection occurs at
peripheral tissues, first free antigens rapidly drain through lymphatics to fibroblastic reticular cell
conduits (FRCC) in the draining LN, and antigen-bearing dendritic cells actively migrate through
lymphatics and arrive at T-cell zone as a later wave [11, 12]. For example, Langerhans cells
resident in the epidermis layer of skin are professional at capturing antigen and relaying danger
signals of infection. After Langerhans cells are matured and activated by antigen, they would
travel through lymphatic vessels to the nearest lymph nodes. The antigen specific T-cell is very
rare, on the order of one in 105 to 106 [13] and thus it is still a difficult task for naYve T-cells to
interact with cognate APCs in the highly cell compact LN. NaYve T-cells spend about 24-36
hours before exiting LNs, returning to circulation to visit next the LN until its life span ends. If
antigen specific T-cells are activated, they will undergo proliferation and differentiation. Within
-2 days of the initiation of a primary immune response, activated T cells and B cells leave their
'home' zones and redistribute to the border between the follicles and T zone, for delivery of T
cell help signals for antibody production [14]. Activated T-cells are capable of exiting the lymph
node, traveling through the bloodstream and transmigrating through the endothelium and
migrating to the site of infection. After the infection is cleared, most of the effectors undergo
apoptosis in peripheral or central organs but a small fraction of cells have much longer life span
as effector memory cells that patrol the periphery or central memory cells that remain to survey
SLOs [15-17].
Multiple factors regulate the complex migration and tissue homing processes occurring
during the primary immune response: (i) Adhesion ligands. For example, entry of naYve T-
cells into LNs is controlled by L-selectin (CD62L) and integrin LFA-1 expression on T-cells,
and correspondingly Peripheral Node Addressin (PNAd) and ICAM expression on lymph node
endothelial cells (high endothelial venules) [3, 18]; T-cells that home to mucosal tissue have high
a4p7 expression but are P-selectin ligand/E-selectin ligand (P-/E-lig) negative, while effector T-
cells that home to skin express high levels of P-/E-lig and low level of c407, because the
endothelial cells associated with infection in skin usually express P-/E-selectin [19].
Interestingly, although adhesion receptors play a critical role in the cascade of rolling, activation,
adhesion and transmigration to transit from blood to other types of tissue, rapidly moving
leukocytes do not require integrin adhesion to migrate through 3D extracellular matrix [7, 20]. (ii)
"Stop " and "exit" signals. Signal accumulation from serial stimulation of antigen-peptide MHC
and TCR engagement induce T-cells to halt migration; therefore T-cells have less motility during
activation and proliferation [21, 22]. The egress of T-cells from lymph nodes is tightly regulated
by spingosine-1-phosphate [23]. (iii) Stromal cell network. The Fibroblastic reticular cell (FRC)
networks in the lymph nodes and spleens are reported to guide T-cell entrance, migration and
territoriality [24] and the follicular dendritic cell (FDC) network (a second type of mesenchymal
stromal cell) constructs the backbone of B follicles. (iv) chemokines and chemokine receptors.
Chemokines and their receptors provide are one of the most important signaling factors that
control leukocyte migration. We will introduce this in the next section.
1.2.2 Chemokines and chemokine receptors
Chemokines are small chemoattractant cytokines, mostly basic and heparin binding, with
common structural features [25]. The specific effects of chemokines are mediated by a family
of seven-transmembrane G-protein coupled receptors [26]. Although many of the signal
transduction pathways are similar for different pairs of chemokine and chemokine receptor
systems, the specific expression, regulation and binding affinity for individual chemokines are
very diverse. The complex system of chemokines and chemokine receptors allow the creation of
many layers of control on the processes of organogenesis, hematopoiesis, neuronal
communication with microglia and leukocyte trafficking in the immune system [27].
Chemokines are usually 6-14 KDa in molecular weight [28] and are grouped into two
major subfamilies, CC and CXC, based on the arrangement of the cysteine residues on the C-
terminus [27]. As highly basic small proteins, chemokines have the potential to bind to
components of the ECM or be captured by other cell surfaces. Many chemokines have been
shown to bind to proteoglycans, which carry acidic sulfate carboxyl groups, especially heparan
sulfate (HS) and its analogs [34-37]. Studies have shown that binding to proteoglycans is
required for proper function of some chemokines (such as CCL2, CCL4 and CCL5 [29]) in vivo,
although these same attractants are functional without GAG binding in vitro [37-39]. However,
as a counter example, studies detailing the interaction between CCL21 and heparin or heparan
sulfate indicate the soluble form of CCL21 bound to polysaccharides has impaired activity [40,
41].
Chemokines are typically secreted by host cells and diffuse into the surrounding tissue to
establish soluble and/or immobilized concentration gradients [4]. Chemokine are believed to
bind to their receptors as monomers [30], while chemokine dimerization is thought to be critical
in binding to glycosaminoglycans on cell surface [31]. Chemokines are typically expressed in
two characteristic patterns, induced or constitutively [27]. Chemokines involved in homeostatic
trafficking such as CCL21, CXCL12, and CCL19 are expressed constitutively in tissue-specific
sites to allow responding cells with corresponding chemokine receptors to home to these areas.
On the other hand inflammatory chemokines such as CXCL 10, CCL3, and CCL5 are induced by
a broad spectrum of inflammatory cytokines. These inflammatory chemokines are displayed on
the surfaces of endothelial cells at sites of inflammation, providing a key signal for arrest of
leukocytes on the endothelial wall for entry into tissues from the blood [4, 32].
Chemokine receptors are typically 340-370 amino acids with 25-80% amino acid identity
[33]. After chemokines bind to chemokine receptors on cell surface, a series of signaling events
can occur and eventually stimulate the cells to migrate to the areas of high concentration
chemokines [5], a process called chemotaxis. Chemokines can also trigger chemokinesis, non-
directed migration stimulated by chemokines present at stimulatory levels without the presence
of functional spatial gradients [34, 35]. The understanding of cell motility will be introduced in
the next section. Chemokines binding to chemokine receptors can induce receptor
desensitization by a phosphorylation-dependent or -independent mechanism [5, 36]. This allows
control over the duration of a cell responding to chemokine stimulation.
Some chemokine receptors are only expressed on a small specific number of cell types and
some are more generally expressed on a broad cell types. CXCR3, CXCR5 and CXCR6 are only
expressed on lymphoid lineage cells while CXCR4 is the most widely expressed receptors [27].
The expression of chemokine receptors on cell surface is tightly regulated by environment.
CCR7 is expressed on naive T-cells but is downregulated after activation [37]. Upon stimulation
of inflammatory stimuli, CXCR3 and CCR5 can be upregulated on the surface of activated T-
cells [3]. With the precise regulation of chemokine and chemokine receptor network, the
immune system can achieve its normal functions.
1.2.3 Cell motility and directionality
Migration is an essential cellular response that helps cells move from one location to
another to facilitate organogenesis, tissue organization and homeostasis. The understanding of
cell migration mechanisms requires an appreciation of physical, chemical, and biological control
at multiple levels, from single molecules, to protein assemblies, to membrane coordination.
Chemotactic cell migration starts from morphological and biochemical polarization caused by a
spatially asymmetric chemokine signal generated across a cell, leading to membrane protrusion
in the direction of higher signaling. Spatially-asymmetric signals are thought to be generated
when a spatial concentration gradient of extracellular cues leads to greater engagement of
receptors on one end of the cell than the other; this difference in receptor engagement front to
back determines the direction of migration. It remains controversial how cells interpret such
spatial cues. Some researchers have proposed that directional sensing is coupled to directional
migration by guiding actin polymerization to induce pseudopods at the "compass needle", where
highest receptor occupancy is inducing local accumulation of intracellular signals [38].
Alternatively, other groups have proposed that cells form randomly-oriented pseudopods, and
pseudopods formed in the direction aligning with the asymmetric extracellular signal would have
a much higher possibility to grow to filopodia (needle-like projections) or lamellipodial
protrusions (broad, flat and sheet like structures) [39]. Both the "compass" and "random
protrusion" mechanisms would lead to the next step of the cell forming and stabilizing actin-rich
protrusions or lamellopodia that maintain the direction of the leading edge. To move forward
ultimately, slowly migrating cells, such as fibroblasts, require adhesion to surfaces to form focal
and stable attachments to pull themselves [34] followed by contraction and release of focal
adhesions at the trailing edge. In contrast, rapidly migrating cells such as leukocytes move by
"amoeboid migration" where strong substrate adhesions may not be required [20]. In either case,
the contractile force for movement is generated by Myosin II interaction with actin filaments.
From the point of view of force generation, three types of forces, actin polymer network
expansion, adhesion and contraction, are balanced and coordinated during cell migration. Cells
can adopt different principles for generating the primary driving force for migration depending
on their environment, i.e., 2D surface vs. 3D matrix, loose 3D matrix vs. dense 3D matrix, or
adhesive 2D surface vs. less adhesive 2D surface, etc. Force generation in amoeboid cell
migration has been reviewed in detail in [20], as have the underlying molecular signaling
mechanisms that drives each step in the migration cycle [40-45].
The trigger for morphological polarization and subsequent migration of cells can be
intrinsic [46] or external [34]. In tissue matrix, cells usually have basal motility in response to
uniform concentrations of chemokines or other motogenic signals [46]. This induced random
migration without directional preference is called chemokinesis. This polarization may be
caused by the microscopic non-uniformities of chemokine ligand concentration in
macroscopically homogeneous environments or by kinetic fluctuations in receptor-ligand
binding [34]. Even during random migration, most mammalian cells exhibit a characteristic
persistence in their directionality over some timescale. In most cases, directional cell migration
is induced by differences in various environmental signals, for example chemotaxis induced by
soluble cues, haptotaxis by a substrate-bound attractant gradient or other guidance cues in the
topology of the extracellular matrix [47], durotaxis in response to mechanical gradients [40], or
electrotaxis in response to electrical field gradients [48]. Here in this thesis, we focus on
chemotaxis.
Many studies have done on describing and exploring the phenomena of chemotaxis. It is
believed that the sense of direction of cells in chemotaxis depends on both the mean
concentration and steepness of the chemokine gradient over the length of the cell body [5]. The
highest sensitivity is achieved around the apparent dissociation constant. At mean concentration
higher or lower than Kd, a steeper gradient is needed to induce chemotaxis [5]. The mechanisms
of chemotactic responses are discussed in more detail in chapters 2 and 4.
1.2.4 Chemotaxis assays
Many in vitro chemotaxis assays have been developed to characterize cell migration and
chemotaxis, including bulk filter assays and imaging assays [49]. The most widely used assay is
the modified Boyden chamber assay, sketched in Figure 1.3A. Cells in suspension without
chemokine in liquid medium are placed on top of a thin porous polycarbonate membrane;
chemokine solution is placed in the corresponding bottom compartment. As chemokine diffuses
into the top compartment, cell will sense the created gradient and migrate through the membrane.
After incubation for several hours, the number of cells in the bottom compartment is counted.
Although this assay is simple and efficient, the relationship between the very brief directional
migration required for cells to be scored as chemotactic in this assay and chemotactic responses
in vivo is unclear. Moreover, the short lifetime of created concentration gradients [50], side
effect of gravity driven migration [51] and confusion with chemokinetic random migration [49]
limit the information provided by this assay.
Imaging assays reveal cell dynamics under the microscope and seek to relate the single-
cell-level response to the specific concentration and concentration gradient of chemoattractants.
The under-agarose assay is probably the most widely used imaging assay, sketched in Figure
1.3B. Two cylindrical wells are formed separated by a defined distance in an agarose gel, one
for chemokine source and the other for a cell suspension. The cells usually migrate underneath
the agarose gel toward the chemokine source well, which still only provides a 2D substratum for
cell migration instead of 3D matrices. Another widely used imaging chemotaxis assay is pipette
assay, sketched in Figure 1.3C. Soluble chemokines are delivered by micropipette to specific
spot in the imaging chamber where cells are cultured in medium. Cell migration towards
chemokine delivery spot can be monitored with microscope. Clearly this method heavily
depends on the operation of individuals and thus well-defined chemokine gradients are not
possibly to control. Recently, microfluidic devices have been applied to create clearly defined
linear, polynomial or even hill-like gradients to study chemotaxis on 2D surfaces, sketched in
Figure 1.3D [52-58]. T cell chemotaxis to linear gradients of CCL19 and CCL12 was studied
using a simple Y channel microfluidic device coated with fibronectin [52]. Although these
imaging-based approaches allow longer-lived, well-defined gradients to be generated and
resulting cellular responses to be characterized, neither the under-agarose assay nor microscopy
studies in microfluidic devices allow the process of cell migration toward an isolated point
source or collection of point sources to be modeled, though this is the situation most relevant to
in vivo cell migration. In addition, presently there are few quantitative chemotaxis studies in 3D
matrices to depict how cells respond to chemoattractants as a function of the mean concentration
and gradient cells encounter at their local position as a function of time [59].
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Figure 1.3 Schematic of in vitro chemotaxis assay [49]. (A) Modified Boyden chamber assay.
(B) Under-agarose gel assay. (C) Pipette assay. (D) Microfluidic chamber assay.
Most recently, two photon/multi photon intravital microscopy imaging techniques have
been used to reveal in vivo cell migration and interaction dynamics [8, 49, 60-62]. Much more
dynamic behaviors of naYve T cells and thymocytes were revealed in thymus, lymph nodes, and
spleen than their sessile appearance in vitro. However the complex interplay of multi cell
environment, matrix properties and control of cells, makes it hard to dissect the phenomena of
chemotaxis to individual cells in the level of single cell dynamics. In addition, in vivo imaging
is only good for 30-60 min and it is impossible to obtain the information of long term cell
migration behaviors.
1.2.5 CCL21/CCL19-CCR 7 and in vivo T-cell motility
In the present work, we have focused on chemokines known to be important for steady
state T lymphocyte homing and recruitment of effector T lymphocytes to inflammatory sites.
First, we are interested in CCL21 and CCL19, the two known ligands for the chemokine receptor
CCR7. CCL21 is expressed constitutively by stromal cells in the T cell areas of lymph nodes as
well as high endothelial cells of mice [63] (but not humans [64]) and attracts naive and memory
T cells, mature dendritic cells, and more weakly, B cells.[65-70] Its expression in SLO is
important for homing of T cells and dendritic cells to the T cell areas of the tissues [71], and
ectopic expression of this chemokine can induce T cell accumulation and lymphoid tissue
neogenesis in some tissues [72, 73]. Mutant plt/plt mice which are deficient in CCL21 and
CCL 19 have severely impaired T cell motility and paucity in lymph node due to the deficiency in
adhesion to high endothelial venue (HEV) [74]. The subcutaneous injection of CCL21,
subsequently transported to the HEV endothelial cells of draining lymph node, is able to rescue T
cell homing [75]. A further evidence of CCR7 ligands controlling T cell motility, subcutaneous
injection of CCL19 in both wild type (WT) and plt/plt mice leads to highly motile T cell
accumulation in the subcapusular region of lymph node [76]. Correspondingly CCR7 deficient
mice exhibit not only severe morphological alternation in lymph node, impaired T/B cell
migration, but also delayed primary immune responses [77].
Recent intravital and whole lymph node explant two photon imaging studies have
revealed several additional features of lymphocyte migration in lymph nodes and the role of
CCR7 ligands in lymphocyte migration in this organ [6-11]. Within the interiors of the T zone
and B follicles, lymphocytes show apparently random migration along the fibroblastic reticular
stromal cells of the lymph node cortex. Lymphocyte migration possesses a "stop and go" pattern,
apparently driven by an intrinsic cycle with a period of about 2 minutes. The peak velocities
reached are as high as 25 pm/min and the average velocities are ~ 10 jim/min [7]. Lymphocytes
travel persistently in one direction within one or several cycles but long term migration exhibits
random features. Importantly, this steady state random motility of T-cells in the T cell zones is
stimulated by the CCR7 ligands constitutively expressed in this zone, as T-cells in chemokine-
deficient plt/plt mice show reduced motility [75, 78]. In contrast to this random motility
behavior within the T zone and B follicles, T-cells and B-cells make sharp turns at the
boundaries of their zones within lymph nodes. Cells reaching the boundary of their compartment
behave as if they encounter a physical barrier at the edge, though no cellular or ECM barrier is
known to separate the T and B cell compartments [7].
CCL21 in lymph node has been stained to depict its concentration profile, as shown in
Figure 1.4. CCL21 exhibits a uniform distribution in T zone and a continuously decreasing
concentration profile in B follicles. This excludes the possibility that chemokines utilize
discontinuous step gradient to define the boundary between T zone and B follicles. The uniform
concentration of CCL21 in T zone might be the reason for the superficial random T cell motility.
The concentration profile of CCL21 also sheds light on how chemokine is regulated by
chemokine producing cells in lymph node. Single cell secrete chemokine to the surroundings;
the secreted chemokines transport in the extracellular space and forms gradient by soluble signal
or bound to ECM around the local source. The denser the collection of chemokine secreting
cells, the more uniform the concentration distributes within the T zone in general. It is
reasonable to establish the continuous decreasing concentration profile through the simple
transport of chemokine by free diffusion and binding to ECM.
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Figure 1.4 CCL21 concentration in lymph node [791. The dash line denotes the boundary
between follicles and T zone. Left panel: B220 staining indicates the location of B follicles;
Middle panel: CCL21 staining with lines 1 drawn from the follicle to deep T zone and line 2
from the follicle to interfollicular T zone; Right panel: Intensity reading out proportional to
CCL21 concentration of line 1 and line 2 is plotted versus distance from the end point of the line.
The reason for the coexistence of two ligands for CCR7 is not clear. Although CCL21
and CCL19 have similar receptor binding affinities and chemotactic potencies [22-24], they
might play different roles in controlling T cell migration. The concentration of CCL21 in lymph
node is about 2-10 pg/ml while CCL19 is only about 100 ng/ml [25]. It has been shown that
binding of CCL19, but not CCL2 1, to CCR7, leads to robust desensitization of CCR7 by receptor
phosphorylation, internalization, and p-arrestin recruitment [26]. A recent study [27] showed
that CCL19 binding to CCR7 induces more internalization of receptor than CCL21. The
internalized CCR7 recycled back to the cell surface but the internalized CCL19 was sorted to
lysosomes for degradation. Although CCL19 triggers rapid receptor desensitization, CCL21 can
continuously stimulate CCR7 for many hours, as shown previously by our laboratory where high
concentration of CCL21 were shown to promote continuous chemokinesis in naYve T-cells for at
least 24 hrs [80]. The different expression levels in the T zone and the differential receptor
desensitization by CCL 19 vs. CCL21 may suggest a hierarchy in regulating T cell trafficking.
1.2.6 Materials for the creation of "artificial secreting cells"
In this thesis, to create a model of cell-based chemokine production in tissues, we sought to
create cell-sized synthetic beads, which could release chemoattractants at tailored rates to serve
as controllable surrogates for secreting cells. We previously reported the use of poly (lactide-co-
glycolide) (PLGA) microspheres loaded with the chemokine CCL20 or bacterial formyl peptides
to generate local dendritic cell chemoattractant gradients [81]. This system was attractive as it
employed a well-established fully bioresorbable material for chemokine release, but the loading
of chemokines (typical of many protein cargos in PLGA particles) was limited to on the order of
~1 wt% of the microspheres, and we found that obtaining functional release of many other
candidate chemokines of interest was problematic, likely due to the harsh microenvironment
within eroding PLGA particles [82-84]. Thus, we searched for an alternative system that could
more efficiently entrap chemokines with higher net bioactivity, and provide "point-source"
release of a broader range of attractants to engineer chemokine gradients in vitro and in vivo.
To meet our design goals, a biocompatible material with tunable release characteristics that
could be prepared in a highly reproducible manner was desirable. The unique physical and
chemical properties of hydrogels, crosslinked polymer networks that can absorb water, allow
hydrogel to be used for biomolecular encapsulation and delivery, and these materials were
identified as an ideal basis for ASCs. The high hydrophilicity of hydrogels provides a friendly
environment to preserve bioactivity of encapsulated molecules [85-88].
Synthetic covalent hydrogels can be prepared by crosslinking water-soluble polymers such
as polyethylene glycol (PEG), polyhydroxyethylmethacrylate (PHEMA), etc. Although
synthetic hydrogels have readily tunable physical properties, such as crosslink density, mesh size
and releasing kinetics, synthetic hydrogels are usually polymerized using free radical initiators
and UV exposure. Radicals can destroy proteins present during gel synthesis for encapsulation
and residual radicals are toxic to cells. This drawback limits biomolecule encapsulation to post-
loading by diffusion and thus limits the amount of molecules can be encapsulated.
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Figure 1.5 Schematic for loading chemoattractants to hydrogel microspheres via post-
synthesis or encapsulation during synthesis.
As an alternative to synthetic covalent gels, there are many natural polymers, such as
chitosan, alginate, agarose etc., which can form hydrogels under very mild synthesis conditions
and where in situ loading of biomolecules can be achieved. Considering that many chemokines
are highly basic small proteins known to reversibly bind to anionic polysaccharides, alginate gels
were immediately an attractive candidate to consider for trapping chemokines. The structure and
crosslink scheme for alginate was shown in Figure 1.6. Alginate is a family of unbranched
polysaccharides, containing p-D-mannuronic-acid and a-L-guluronic acid on the backbones.
Guluronic acid blocks of two different alginate chains efficiently coordinate with divalent cations
such as calcium in a cooperative manner (Figure 1.6), allowing divalent cations such as calcium
to ionically crosslink alginate at relatively low total concentrations into a solid hydrogel. Due
to their inert composition and ease of preparation, more importantly, the negative charges of
alginates provided by carboxyl groups provide sites for possible interaction with basic proteins,
alginate gels have been used to load many therapeutic proteins, such as basic fibroblast growth
factor (bFGF), CD40 ligand (CD40L), interleukin- 17 receptor (IL-1 7R), tumor necrosis factor
receptor (TNFR-Fc), nerve growth factor (NGF), etc. [89]. Both encapsulation during alginate
bead synthesis [90] and electrostatic absorption after synthesis [91] were used previously to load
charged proteins to alginate matrices. The molecular weight, crosslink density, percentage of
polymers and affinity of interaction with chemokines will determine the release kinetics of
loaded cytokines [89].
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Figure 1.6. Structure and crosslink chemistry of alginate [891.
1.3 Aims and scope of thesis
In this thesis, we have combined computational models and a novel reductionist
experimental system to study how chemoattractant secretion in tissues governs local leukocyte
migration responses, focusing particularly on chemoattractants that play a key role in the
initiation of adaptive immune responses and homeostasis of the immune system. We have firstly
analyzed chemoattractant concentration gradient development around individual cells using a
mathematical model, taking into account the interaction of chemoattractants with tissue matrix.
This analysis helped to guide the design of cell-sized chemokine releasing hydrogel
microspheres, i.e., artificial secreting cells (ASCs). Then we have chosen suitable material
platform to prepare these artificial secreting cells which release chemokine sustainable at tailored
rates in the physiological range. The released chemoattractants could create controlled soluble
and/or immobilized concentration gradients to mimic the chemokine secreting cells in tissue
matrix. We have chosen collagen hydrogels, which have mechanical properties and adhesion
ligands comparable to lymphoid tissue, as surrogate for ECMs. With the simple in vitro model,
we have analyzed human T-cell chemotaxis to "point" source of CCL21 and CCL19. The
specific aims of this work were:
Aim 1: First, we used a simple model to theoretically understand the concentration gradient
profile developed around single chemokine secreting cell, illustrated in Figure 1.7. This model
was based on the assumption that chemokines are secreted in an omni-directional manner
uniformly from the surface of cells. The degradation of secreted chemokines and interaction
with tissue matrix would be considered. We calculated the receptor occupancy gradients, i.e.,
the actual number difference in occupied receptor between cell front and rear, to quantitatively
predict cell chemotactic response, from concentration gradients. Due to the natural difference in
CCL21 and CCL19 in inducing corresponding CCR7 desensitization, we also included receptor
desensitization kinetics in the case of determining CCL 19 receptor occupancy gradients. Further
to understand the more complex situation in vivo, we simulated the overlapping gradient fields in
a collection of uniformly distributed dense cells. Our theoretical modeling has employed all
parameters comparable to physiological settings to our best knowledge. This work provided us
a general quantitative understanding of how individual cells would create concentration field and
of how cells would respond to such gradients.
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Figure 1.7 Schematic of concentration profile develop around isolated cell [92].
Aim 2: We designed cell-size microspheres releasing chemoattractants, i.e. artificial
secreting cells (ASCs), at controlled rate comparable to physiological setting to mimic
chemoattractant secreting cells, with the knowledge gained in Aim 1. Apropos of this challenge,
we screened various hydrogel biomaterials and developed methods for making microspheres,
loading various chemoattractants to the microspheres, characterizing the release of
chemoattractants from these ASCs, and quantifying the concentration gradient field created
around individual ASCs using semi-experimental approaches. We evaluated the biological
functionality of these ASCs using both traditional modified Boyden chamber assay and time-
lapse video microscopy imaging assay for direct visualization of cell migration response to these
ASCs. This work provided us a solid framework to prepare and characterize ASCs for a series
of chemoattractants of interest, not only for the use in understanding cell chemotaxis response to
"point" source in Aim 3, but also for potential application as adjuvant materials in vaccines and
cancer immunotherapy.
Aim 3: We applied a reductionist in vitro model to investigate cell chemotactic responses
to "point" sources, illustrated in Figure 1.8, in which fluorescent dye labeled cells were mixed
with ASCs at defined density in collagen hydrogel and cell migration was tracked using time-
lapse video microscopy. Single cell migration was analyzed under various experimental
conditions, including from tailoring release rate of ASCs to various chemoattractants (CCL2 1,
CXCL12, CCL19 and CXCLlO), from various cell types (human T-cells and dendritic cells) to
tuning the density of ASCs or the background chemokine concentration. We employed a multi-
dimensional analysis to these single cell tracks, from measuring the frequency of cells reaching
individual ASCs, to recording the chemotactic path history of these cells, to quantifying the
status of cells staying or leaving ASCs. This work provided systemic and quantitative analysis
of single cell chemotaxis to gain rich information of single cell chemotaxis to discrete point
sources and shed light on the roles that chemokine gradient in regulating cell interaction, such as
T-APC interaction during the phase of naYve T cell priming or recruitment of memory T-cells
during recall responses.
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Figure 1.8 Schematic of attraction of T-cells to artificial secreting cells.
Chapter 2 Gradient formation around chemokine secreting
cells
2.1 Introduction
Chemoattractants play important roles in directing cell migration, organ development and
tissue organization, as concentration gradients of these factors direct cell migration in tissues [1,
28, 32, 37, 93, 94]. Because the characteristics of the attractant gradient (the spatial
concentration profile over time) dictate the cell migration response, understanding how
chemokine gradients are generated is critical to understanding directed cell migration. Secondly,
it is of great interest to understand how cells interpret such gradients and migrate accordingly.
To date, studies of leukocyte chemotaxis have typically focused on creating well-defined
attractant gradients to facilitate interpretation of cell migration responses, with little attention
paid to the nature of chemoattractant concentration profiles that might be expected in physiologic
settings. A quantitative understanding of concentration gradient fields developed around a single
cell or collection of cells in a tissue would shed light on migration responses observed in vivo
and also provide guidance into key issues for involved in exploiting chemotactic responses in
tissue engineering or therapeutic settings.
Typically chemokines are secreted by single cells in soluble form, diffuse through the
matrix, and form soluble and/or ECM-immobilized gradients by coupled reaction/diffusion [95].
Therefore the transport of chemokines through tissue is the main process to understand
chemokine gradient formation. There are a multiple factors that affect this process, including: (i)
Secretion rate of chemokines from cells: The secretion of chemokines, cytokines or morphogen
from cells is controlled by a series of genetic and biochemical cellular events such as activation
of key genes, DNA transcription, RNA translation, transport from ribosome, to endoplasmic
reticulum for further synthesis and modification, to Golgi apparatus for glycosylation, to
secretion vesicles for exocytosis. (ii) Diffusive property of chemokines through tissue matrix:
With varying molecular weight of chemokines and density of tissue matrix, secreted molecules
usually have different diffusivity. (iii) Chemokine interaction with matrix: Usually chemokines
are positively charged and many have been formally shown to bind to GAGs present in the ECM
[29, 96]. (iv) Proteolytic degradation of chemokines in tissue matrix: The presence of proteolytic
enzymes and other pathways leading to clearance of secreted chemokines regulate the
effectiveness of chemokines and prevent chronic inflammation triggered by chemokine-mediated
influx of leukocytes into tissues [97]. (v) Interstitial flow: Living biological tissues are dynamic,
and lymphatic flow as well as physical movement can induce pressure differences and thus
interstitial flow within tissue [98]. This convection could affect the transport of chemokine
around cells and might induce asymmetric concentration gradient profiles [99, 100]. (vi) Density
of cell sources: Increasing density of chemoattractant-releasing cell sources leads to overlapping
concentration gradients around individual cells, and thus affects chemotactic "pull" toward any
individual cell. Though physiological ranges for many of these processes and their governing
parameters are known, it is poorly understood how each of these factors integrates to control the
quantitative nature of gradients generated around attractant-secreting cells, or which factors
dominate gradient generation.
In prior studies, Francis and Paisson used a simple model of an isolated cell in infinite
space to understand the development of concentration gradients of cytokines secreted by single
cells [92]. They found that the effective communication distance, over which a single cell can
meaningfully propagate a soluble signal, was determined both by biological secretion rate of this
soluble cytokines and the physicochemical transport processes. This effective communication
distance was estimated to be 250 pm for typical cytokines and it took 10-30 min to reach
effective communication to this distance. However, in this work the analysis of effective
communication distance for responder cells was based on models of cytokine signaling assuming
that only absolute concentration of the secreted factor was important, and no information of the
gradient of secreted factors was considered. By contrast, as cells respond to chemokines, both
absolute concentration and more importantly concentration gradient play critical roles in
regulating cell migration. Fleury et al. analyzed morphogen gradient formation around single
cells, considering the effect of matrix binding, degradation and interstitial flow [99]. This work
demonstrated that pericellular gradients could be greatly amplified by attractant-matrix
interactions and subtle interstitial flow could drive asymmetric gradient formation. However, in
this study the gradient was considered only in terms of a concentration change occurring over
individual cells. Chemotactic responses, however, are regulated by differences in attractant
receptor occupancy which are related to but not synonymous with attractant concentration
changes.
Early studies by Zigmond [101, 102] provided experimental support for the concept that
chemotactic and cell polarization responses of leukocytes are governed by cells sensing
differences in attractant receptor occupancy at the front vs. rear of the cell. They have shown
that leukocytes can sense and orient in response to a 2% change in chemokine concentration
across the cell body (-10 ptm) at optimal concentrations near Kd, and the threshold receptor
occupancy difference for robust chemotactic migration has been estimated to be ~10 receptors
across the length of a cell. More recently, Herzmark et al. used microfluidic devices to create
temporally stable, well-defined gradients to revisit this issue [103], and in agreement with
Zigmond's findings of thirty years earlier, they found that the chemotactic response of
neutrophils (as measured by a chemotactic index) correlated well with the difference in the
fractional occupancy of receptors between the front and rear of cells. Consideration of fractional
receptor occupancy works well when the number of receptor on the cell surface is not affected by
the stimulation of chemokines. With the possible change of total receptor number on cell surface,
the fraction of occupied receptor would not be an accurate predictor. Actually as shown in
Zigmond's earlier studies [102], absolute occupied receptor differences across the responding
cell can accurately predict chemotactic responses even in the presence of receptor internalization.
Here, taking CCL21 and CCL19 as model chemokines, we have simulated CCL21 and
CCL 19 concentration gradient development around single cells using a simple model of isolated
cell in infinite space, and sought to marry the careful consideration of how migration responses
are governed by receptor occupancy as first postulated by Zigmond with a holistic analysis of
gradient generation by secreting cells in tissue. The clearance/degradation of secreted
chemokines and interactions with tissue matrix were considered. As indicator for predicting cell
chemotactic response, we calculated receptor occupancy gradients, i.e., the actual number
difference in occupied receptors between the front and rear of responding cells as a function of
their position in the local chemoattractant gradient. Due to the natural difference in CCL21 and
CCL 19 in inducing CCR7 desensitization, we have included receptor desensitization kinetics in
the case of determining CCL19 receptor occupancy gradients. Further to understand the more
complex situation in vivo, we simulated the impact of cell source density in the tissue and the
creation of overlapping gradient fields in a collection of uniformly distributed dense cells.
2.2 Methods
2.2.1 Computational model and governing equations
We modeled the secretion and transport of chemokine from isolated source cells using
analytical solution or COMSOL finite element modeling software to solve the equations for
coupled reaction/diffusion appropriate to the physical system. The secreting cell was modeled as
a sphere with diameter 20 ptm located in an infinite space or in the center of a cubic space,
Chemokine secretion was modeled as production of chemokine at a constant rate at the surface
of the cell. The transport of the chemokines from the surface to the surroundings was modeled
as diffusion without convective flow, giving for the concentration change with time:
ac
= D - Rp - RM
where C is the concentration of the attractant, and D is the diffusion constant of chemokine in the
tissue matrix. Following prior work [81], because the porosity of the tissue matrix is on length
scales much greater than the size of the chemokine, D was taken as half the diffusivity of
chemokine in water, Do. Do was estimated using the empirical relationship [50, 104]:
A
Do = MWI/ 3
where A is a constant, 2.82x 105 cm2/s (g/mol)" 3, and MW is the protein molecular weight.
These relationships gave DCCL21 = 6.5x10~7 cm2 /s and DCCL19 7.21X10~7 Cm2/s. The reaction
term R, accounts for the chemokine proteolysis and other modes of clearance (such as
consumption by non-relevant cells or lymphatic drainage) by a lumped first-order reaction, and
the parameter selection will be discussed in Section 2.2.2. The reaction term RM accounts for
chemokine binding to or being released from the matrix, and values of this reaction rate were
chosen specifically for CCL21 binding to heparan sulfate as done by Sheilds et al. [100] and will
be discussed in detail in Section 2.2.3.
2.2.2 Chemokine decay
Modulation of chemokine activity by proteases provides a critical layer of regulation
during cascades of host defense to enable rapid enzymatic modulation of chemokines.
Chemokine decay by proteases can be described by Michaelis kinetics as following:
R kcatEOS
Km + S
where S denotes the substrate concentration, which is the chemokine concentration C here, and
kcat is the catalytic rate constant and Km is the Michaelis equilibrium constant. The substrate
concentration S we discussed here, is fairly small compared to Km, so we can simplify the
solution as:
RP = kcatEo C = kC
where kp = kcatEo/Km. To simplify calculations, we considered all modes of attractant clearance
using this lumped first order clearance term.
The degradation of chemokines and growth factors by proteases has been extensively
studied in the literature. For example, basic fibroblast growth factor (bFGF) was investigated in
[105]; Degradation of a series of chemokines including CXCL12, CXCLlO, CCL5, etc., by
CD26/dipepetidyl peptidase IV have been extensively studied in [106], and showed striking
selectivity with the chemokine family; a more detailed review of chemokine modification on
carboxyl-terminal proteolysis or amino-terminal proteolysis was discussed in [97]. However, the
kinetic parameters for CCL21 and CCL19 degradation were not available in the literature to our
knowledge. In the study of chemokine proteolysis by CD26, the kcat ranges from 0.0026/s to
12/s and Km varies around 1-25 pM. In the normal human plasma, the enzyme CD26/DDP IV
(~175 kDa) was 25 U/l with a specific activity of 22 U/mg, which is equivalent to 5.7 nM of
active enzyme [107]. Therefore, we estimated k, based on the kinetics measured for other
chemokines in this paper varying from 0.00002/s to 0.03/s and made calculations with k, =
0.0002/s, 0.001/s or 0.01/s to study the effect of degradation rate on the creation of gradients
around a single cell. As a point of reference, the degradation rate for other growth factors, such
as bFGF was measured as ~ 10-6/s [105] and VGEF was estimated to be 10-4-10-2/s [108]. In
Fleury and Swartz's study [99], kp was chosen as 0.2/s to exaggerate the effect of proteolysis as
the same magnitude as transport to examine its effect.
2.2.3 Chemokine binding to matrix
Chemokines are typically secreted from cells in a soluble form. As highly basic small
proteins, chemokines have the potential to bind to ECM proteins or be captured by GAGs on
other cell surfaces. Many chemokines have been shown to bind to proteoglycans, which carry
acidic sulfate carboxyl groups, especially heparan sulfate (HS) and its analogs [34-37]. CCL21
binding equilibrium to heparan sulfate on proteoglycans in matrigel was experimental measured
and used to predict CCL21 pericellular concentration with mathematical simulation in [100]. We
considered the interaction between CCL21 and the surrounding matrix using the reaction term:
RM = k;CM - krCb
where M is the concentration of chemokine binding sites in the matrix and Cb is the
concentration of chemokines bound to matrix, kf was 9.3x10 4 M'1s-1 and kr was 1.2x10-4 s-1,
measured in [100]. In our calculations, we determined the effects of matrix binding by varying
the concentration of matrix binding sites from 1.2 nM to 1.2 [IM. For CCL19, it was assumed
that there is no interaction with matrix, based on published analyses of CCL 19 binding to GAGs
[96, 109-111] and our own experimental measurements described later.
2.2.4 Receptor desensitization and recycling
After receptor is ligated with a chemokine ligand, it can trigger downstream signaling and
can be desensitized and internalized in a phosphorylation dependent or independent manner [5,
36]. We employed a simple model for receptor internalization and desensitization to analyze the
binding of CCL19 and CCL21 to CCR7, illustrated schematically in Figure 2.1.
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Figure 2.1 Reaction scheme for receptor desensitization, internalization and recycling. The
kinetic reaction network was modified from [112].
This simple receptor desensitization, internalization and recycling model was modified
from Butcher and Lin's work modeling binding of chemokines to CCR7 [112]. Here, R is the
number of free receptors on cell surface, Re is the number of chemokine-occupied receptors, Rdes
is the number of desensitized receptors on cell surface and Ri is the number of internalized
receptors. Correspondingly, k0, is the binding rate of chemokine to receptor, koff is dissociation
rate of chemokine from receptor, kdes is the desensitization rate, ki is the internalization rate and
kup is the rate of upregulation of receptor to the cell surface. This reaction scheme was described
using a series of kinetic equations:
d Rc
= koRC - kof Rc - kdesRc
dR
dt -kO1RC + koff Rc + kupRi
dRds = kdesRc 
- kiRdes
RO = R + Rc + Res + Ri
It is assumed that these reactions reach steady state and thus the active receptor ligated with
chemokine was expressed as a function of these kinetic rate constants and total initial surface
receptor number,
=R1 + koff + kaes + kdes + kaes
R konC k up
Here, Ka = !"" is the affinity or dissociation constant of chemokine to receptor. Likewise,kon
we also define constantsKn* = , Kn-'s = L- and K1 , = for convenience. CCL19 andkon i up
CCL21 bind to CCR7 with comparable affinities (both with estimated KDS of a few nM [68, 113,
114] and thus we chose KdCL2  = KdccL 9 = 5 nM. However, unlike CCL21, CCL19 triggers
rapid internalization of CCR7 and desensitization of CCR7 signaling [115-117]. In order to
determine the kinetic parameters,Kon , Kf'S andI4,, we fitted experimental measurements of
the surface receptor expression following stimulation with various CCL19 concentrations to the
predicted functional form at steady state:
RT R + Rc + Rdes 1+ K*C+Kd+ Kdes
R Kon Ka + K " des
T R_+__+__e C
K+Kdes + KS
The measured total surface receptor expression was obtained using flow cytometry
measuring surface-expressed CCR7 before and after incubation with various concentrations of
CCL19 for 0.5 hr (Figure 2.2). The fitted parameters were Kode*S = 3 nM, Kfds = 8 nM, and K,"S
= 6 nM.
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Figure 2.2 Downregulation of CCR7 expression on human T-cells after CCL19 stimulation.
Flow cytometry was used to measure CCR7 surface expression on resting human T-cells after
incubation with CCL19 at the indicated concentrations for 0.5 hr at 37'C, followed by washing
with cold medium 3X and staining with APC-CCR7 Ab (3D12, Ebioscience). The data was
shown with mean ± SEM as open circle and the solid line was fitted to receptor desensitization
expression in Section 2.2.4, KD = 5 nM, kdes/kon = 3nM, kdes/kin =6 nM, kdes/kup = 8 nM.
2.2.5 Cell density
In the simple isolated single cell model, a single chemokine-secreting cell was placed in the
center of an infinite space. To model secreting cells present at a finite density in tissue, we also
conducted simulations of concentration gradients developed around individual cells located in a
field of cells uniformly distributed on a square lattice in space with various densities. The
dimension of the cubic space, a, in which individual cells were located, i.e., the spacing between
neighboring cells, was varied from 50 pm to 500 pm.
2.2.6 Boundary conditions and solutions
The model is based on the assumption that the cells are perfectly round with radius p = 10
pm and are secreting chemokines symmetrically from their surface at constant rate, Q, 0.01-1
pg/hr/cell covering the physiologic ranges estimated for lymphatic endothelial cells and mature
dendritic cells [118-121]. Single secreting cells were modeled in the center of an infinite space
as in [92] while individual secreting cells surrounded by other secreting cells in a tissue were
modeled as occupying the center of a defined cubic space, with dimensions equal to the distance
between secreting cells. The boundary condition was set to zero chemokine flux. The solution to
the governing equation considering chemokine degradation only in infinite space has an
analytical solution for the steady state:
Qexp (- !r)
41rDr ( Lp+ i)exp( - !p)
The transient solution for the above system and the steady state solution to the governing
equation considering both chemokine degradation and matrix binding with defined space
dimensions were solved using the transport of dilute species module in COMSOL modeling
software (COMSOL Inc., Burlington, MA). Solutions of the diffusion equations were solved for
free triangular FEM mesh points of maximum spacing, 8 [tm and minimum spacing, 16 nm.
2.2.7 Occupied receptor difference ARe
The chemokine concentration profile determined from the above calculations is assumed to
influence the migration response of nearby cells by connecting secreted chemokines with
appropriate receptors on the responding cell. The difference in actual occupied receptor number
between the front and back of responding cells (which we will also refer to as the receptor
occupancy gradient, ARC), was calculated from the equations governing receptor-ligand binding
accounting for the concentration gradients of attractant. For non-desensitized receptors after
ligand stimulation, the receptor engagement gradient was calculated as:
(C + Kd) dC
ARc =KRT-Ar
C2 (1 +d)2 dr
where Ar is the length of the responding cell from front to rear. For desensitizing receptors,
the Lin/Butcher model as described above was used to capture desensitization, internalization,
and recycling processes. In this case, the receptor occupancy gradient was defined as:
(C+Kes + K) dC
AR C - KoS + Ar
T K esC+ Kd + Kdes+Kdes)2 dr
2.2.8 Summary of model parameters
For convenience, all the model parameters used in this chapter are summarized in Table 2.1.
The default numbers used in this model are shown in bold type.
Table 2.1 Summary of model parameters
Basic
Degradation
Matrix
binding
Radius of chemokine 10
secreting cell, p (pim)
Radius of receiving cell, o 5
(pm)
Secretion rate (pg/hr/cell)
Diffusion constant (cm2/s)
Space dimension, a (ptm)
Rate constant (s-')
forward rate constant, kf
(M'Is'1)
0.01
9.3x10 4
Backward rate constant, kr 1.2x10 4
(s~i)
Binding equilibrium 1.29
constant, Km (nM)
Binding site 1.2 0.12 0.012
concentration, M(pM)
Km/ M 1000 100
Receptor CCL21 CCL19 CXCL12 CXCL1O
binding and Affinity, Kd (nM) 5 5 3.0 2.5
desensitization
Desensitization constant, 0 3 NA 1
Kones (nM)
Internalization constant, 0 6 NA 0.2
K es(nM)
Upregulation constant, 0 8 NA 1
Kpes (nM)
2.3 Results
2.3.1 Creation of attractant gradients around chemokine-secreting cells
To gain a theoretical picture of how chemokine secretion translates into chemoattractant
receptor occupancy gradients that direct leukocyte migration, we first modeled the secretion of
CCL21 by isolated "source" cells secreting chemokine at a constant rate, and determined the
steady-state profile of receptor occupancy for CCR7-expressing cells exposed to this attractant
gradient. These initial calculations were made assuming no matrix binding of the chemokine, and
considering clearance mechanisms (proteolytic degradation, consumption by non-responding
cells, etc.) via a lumped first-order degradation rate constant estimated from experimental
measurements of chemokine degradation by serum proteases [97, 105, 106, 108, 122] (see Table
2.1 for summary of model parameters). We considered cells secreting CCL21 at rates covering
the physiologic ranges estimated for lymphatic endothelial cells and mature dendritic cells [118-
121]. As illustrated in Figure 2.3A, in the absence of matrix binding, the concentration gradient
of CCL21 developed around individual secreting cells releasing chemokines at rates in the
physiological range reaches steady state within minutes, and thus we subsequently focused on
calculation of steady-state gradient characteristics.
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Figure 2.3 Physiological chemokine secretion rates produce steady-state CCL21 gradients
that do not saturate responding cell CCR7 receptors and extend up to ~150 sm around
individual source cells. Calculations were made of chemoattractant concentration profiles
developed in tissue by a single isolated secreting cell (20 tm diameter) releasing CCL21 at a
constant rate. Plots show chemokine concentration and receptor profiles developed around
individual secreting cells as a function of radial distance from the secreting cell surface (at r = 0).
(A) Temporal evolution of CCL21 concentration profile calculated for a secretion rate of 1
pg/hr/cell, demonstrating steady state achieved within ~15 min. (B-D) Steady-state CCL21
concentration profiles around an individual secreting cell were calculated for different attractant
secretion rates covering the physiologically-relevant range: (B) Concentration, C/Kd; (C) The
resulting fractional receptor occupancy, Re/RT; (D) Receptor occupancy gradient, AR, were then
determined for responding cells expressing 10,000 non-desensitizing CCR7 receptors.
Horizontal dashed line in (D) shows the estimated threshold level of ARc required for directional
migration by responding cells and Vertical dashed lines in D shows the estimation for rm at
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P
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varying secretion rate. Shown in (E) is the variation in the maximum distance an attracting
gradient extends from the nearest source cell, r,.
The concentration of attractant at a given distance from the source cell determines the
fractional occupancy of chemokine receptors on responding CCR7-expressing cells at that
location, RI(R+Re) (number of attractant-complexed receptors divided by total number of active
cell surface receptors). The attractant concentration difference over the length of a given
responding cell in turn generates a difference in number of occupied receptors between the front
and rear of the cell, ARe. Both Rc/RT and AR, impact the migratory response to chemoattractant
concentration gradients, by controlling the magnitude of the chemokine signal and the magnitude
of the directional component of this signal, respectively. Combined modeling and experimental
measurements of ARc have suggested that a threshold difference in receptor occupancy of ~10
receptors is required for leukocytes to sense and respond to attractant gradients [5, 103, 112].
Notably, CCR7 is known to be resistant to desensitization by CCL21, which triggers minimal
receptor downregulation and elicits sustained stimulation of T-cells, even following hours of
exposure to substantial concentrations of ligand [35, 76, 115]. Thus, we calculated the
chemokine concentration profiles and receptor occupancy gradients of responding cells
expressing 10,000 non-desensitizable CCR7 receptors in the vicinity of a cell secreting CCL21
(Figure 2.3B, C). The secretion rate directly determined both r", the maximum distance a
functional gradient extended from the cell (assuming a threshold of ARC > 10 receptors over a 10
pm cell body for chemotaxis, Figure 2.3D), and the peak strength of the gradient (i.e., maximum
AR, and RO/RT, Figure 2.3E).
To evaluate the sensitivity of our model on other parameters, such as clearance rate and
total chemokine receptor number on surface, we varied the rate of chemokine clearance rate over
a 25-fold range or the number of receptors expressed per cell over a 6-fold range. This led to
modest changes in the predicted receptor occupancy difference generated on responding cells but
did not alter the qualitative characteristics of the receptor engagement profiles predicted (Figure
2.4A, B).
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Figure 2.4 Effect of degradation rate and total receptor number on receptor occupancy
gradients. Calculations were made of chemoattractant concentration profiles developed in tissue
by a single isolated secreting cell (20 pm diameter) releasing CCL21 at a constant rate of 1
pg/hr/cell. Plots show chemokine concentration and receptor profiles developed around
individual secreting cells as a function of radial distance from the secreting cell surface (at r = 0).
2.3.2 Effect of matrix binding
The qualitative features of these predicted attractant and receptor occupancy profiles
remain true if more complex physiologic situations are assumed, though the quantitative details
are altered. For example, CCL21 can bind to proteoglycans in the extracellular matrix and on cell
surfaces [96, 123-125]. If secreted chemokine binds to matrix, gradients with qualitatively
similar features are formed (irrespective of whether only free soluble attractant is active, only
matrix-bound attractant is active, or both soluble and matrix-bound attractant are active), though
high densities of high-affinity matrix binding sites lead to gradients that extend shorter distances
from the secreting cell (Figure 2.5).
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Figure 2.5 Effect of matrix binding on receptor occupancy gradients. Calculations were
made of chemoattractant concentration profiles developed in tissue by a single isolated secreting
cell (20 pm diameter) releasing CCL21 at 1 pg/hr/cell, and with k, = 0.001/s. Plots show
chemokine concentration and receptor profiles developed around individual secreting cells as a
function of radial distance from the secreting cell surface (at r = 0).
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2.3.3 Effect of receptor desensitization
Also critical to the chemotactic response is the role of receptor internalization and
desensitization. Here it is interesting to contrast the two ligands for CCR7: CCL19 and CCL21
bind to CCR7 with comparable affinities (both with estimated Kds of a few nM [65, 68, 113,
114]), but unlike CCL21, CCL19 triggers rapid internalization of CCR7 and desensitization of
CCR7 signaling [115-117]. We thus next assessed the impact of receptor downregulation and
desensitization on the response of leukocytes to a local secreting cell. Using a simple model of
ligand-induced receptor desensitization developed by Lin and Butcher [112] (see methods) with
desensitization parameters obtained by fitting experimental measurements of CCR7
downregulation by CCL19 binding to human T-cells, we calculated the expected receptor
occupancy and ARc induced around CCL19-secreting cells. As shown in Figure 2.6, CCL19 in
general elicited weaker peak receptor occupancy gradients compared to CCL21 at a given
secretion rate. At high CCL19 secretion rates characteristic of dendritic cells [120], these
calculations predict receptor desensitization by CCL19 will lead to a substantially weaker
receptor occupancy gradient near the secreting cell compared to an equivalent gradient of CCL21
(~25-fold lower AR, for CCL19 gradients near the source cell).
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Figure 2.6 CCL19 induced CCR7 desensitization and downregulation drastically affect
receptor occupancy gradients, especially at high secretion rate. (A) Fraction of occupied
receptor; (B) Total surface receptor as a ratio of total initial receptor; (C) Receptor occupancy
gradients. Dashed lines in A and C show profiles for CCL19 stimulation and solid lines for
CCL21 stimulation. Calculations were made for cells with diameter of 20 pm and constantly
secreting CCL21 or CCL19 at rates of 0.01, 0.1 or 1 pg/hr/cell.
2.3.4 Effect of cell density
Chemoattractants are often produced by collections of cells in tissues (e.g., CCL21
produced by stromal cells of inflamed lungs [126] and skin [127] or lymphoid tissues [71, 74-77],
and thus we next determined the attractant/CCR7 occupancy gradients that would develop
around individual CCL21-secreting cells in a field of uniformly-spaced secreting cells (Figure
2.7A), assuming reversible binding of chemokine to matrix, as a function of the density of
secreting cells in the tissue. As shown in Figure 2.7B-C, as the density of attractant-secreting
cells increases, the steady-state concentration of chemokine and the net fraction of occupied
receptors on nearby responding cells increases. In turn, the functional range of the chemokine
gradient around each secreting cell contracts as the source cell density increases, irrespective of
whether soluble (Figure 2.7D) or matrix-bound attractant (Figure 2.7E) is preferentially
stimulatory. High steady-state concentrations of CCL21 (-250 nM) comparable to the levels
experimentally measured in lymph nodes [25] are expected for secreting cell densities of -50 pm
between sources. However, even in this setting of dense source cells, these calculations predict
locally functional receptor occupancy gradients would exist at short distances (a few cell
diameters) around each secreting cell. Thus, responding leukocytes should be capable of sensing
local gradients around individual attractant-secreting cells even when high densities of secreting
cells are present in a tissue.
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Figure 2.7 Concentration profile developed around individual cells is dependent on the
density of chemokine secreting cells due to overlapping gradient fields. Calculations were
made for secreting cells with diameter 20 pm and constantly secreting CCL21 at a rate of 1
pg/hr/cell. (A) Schematic illustrating model geometry of overlapping gradients developed in a
dense cell field; False color indicates the concentration gradients and the dashed box indicates
the modeled space around an individual secreting cell. (B-J) Concentration gradient profile
plotted for the one single cell in the dashed box indicated in (A) as a function of cell density: (B,
E ,H) chemoattractant concentration; (C, F, I) Fraction of occupied receptors; (D, J, I) Receptor
occupancy gradient assuming only soluble chemokines are active (B, C, D), or only matrix-
bound chemokines are active (E, F, G), or both forms of chemokines are active (H, I, J). Spacing
between cells was indicated in the labels.
2.4 Discussion
We employed a simple mathematical model but with reasonable consideration of the
complexity of cells producing chemoattractants in a tissue matrix to illustrate the development of
chemokine gradients around individual source cells. Previously Pallson and Francis [92] applied
a simple model to understand the maximum effective communication distance that a single cell
can reach. They estimated that a typical cell can reach maximum effective communication
distance, 250 im, within 10-30 min. Here, we have taken into account the degradation of
chemokine in the tissue by proteolytic enzymes, interaction of chemokines with matrix, and the
density of chemokine secreting cells, in our model to understand more realistically what the
concentration gradients around a single cell. We used the difference in actual number of
occupied chemokine receptor between front and rear of cell, as an indicator of chemotactic
response of responder cells. By comparing to the sensing threshold ~10 receptors, we defined
our maximum stimulation distance for chemotaxis, ~ 150 im and this communication distance
can be achieved within 15 min. As shown in Lin and Butcher's work [112], they found it was
critical to have the mechanism of desensitization to allow cells responding to a distant site of
chemokine source. They built nice modeling frame work for receptor desensitization,
internalization and upregulation that I could base my calculation on. However in their model,
the concentration profile was a hypothesized concentration profile. Here, we included this
complicated chemokine receptor desensitization, internalization and upregulation kinetics into
our receptor occupancy gradient prediction from the calculated concentration gradient around a
single cell. And the kinetic parameters for CCL 19 were fitted from experimental data.
Our model calculations make several key predictions about the nature of cell-produced
chemokine gradients and the receptor engagements triggered in nearby chemokine receptor-
expressing cells: (1) Receptor saturation is not expected to occur for a responding cell exposed to
any of these physiologic chemokine secretion rates, even in close proximity to the secreting cell;
(2) higher chemokine secretion rates increase r,, but this parameter asymptotically approaches
a plateau peak value above -0.5 pg/hr/cell, which limits the maximum distance from the
secreting cell that a chemotactic response can be elicited (< 200 im); and (3) the strength of the
chemotactic response (determined by ARC) should increase as responding cells approach the
secreting cell, irrespective of the secretion rate; (4) If secreted chemokine binds to matrix,
gradients with qualitatively similar features are formed (irrespective of whether only free soluble
attractant is active, only matrix-bound attractant is active, or both soluble and matrix-bound
attractant are active), though high densities of high-affinity matrix binding sites lead to gradients
that extend shorter distances from the secreting cell; (5) chemokine receptor desensitization
could significantly reduce both the peak receptor occupancy gradients near cell proximity and
the maximum distance that enough receptor occupancy gradient could trigger cell responses; (6)
overlapping of concentration gradient in dense field of chemokine secreting cells could contract
the maximum stimulation distance drastically but local chemotaxis/attraction at the surface of
individual chemokine secreting cells is still expected.
2.5 Conclusions
We have applied a mathematical model to understand the key characteristics of
chemoattractant gradients secreted from single source cells. In the model an isolated cell with
diameter of 20 pm is assumed to secrete chemoattractant in a uniform omni-directional manner
at physiological rates of 0.01-1 pg/hr/cell. During the transport process of chemoattractants, we
considered the diffusion of soluble form, binding to matrix and degradation by proteolytic
enzymes. Based on the calculated chemoattractant concentration gradients, we predicted the
chemokine receptor engagement gradients for receiving cells. By comparing with the threshold
for receptor engagement gradients, ~10 ligand-engaged receptor difference between front and
back of responding cells, we could estimate the maximum stimulation distance to be effective in
triggering chemotaxis of responding cells for chemoattractant gradients developed around single
source cells, -150 pim. This characteristic maximum stimulation distance is a function of
multiple parameters including secretion rate of the source cell, diffusion constant of
chemoattractant, interaction with matrix, degradation or clearance of chemoattractant in the
tissues, and the density of source cells. We analyzed the concentration gradient and receptor
engagement gradients for CCL21 and CCL19, two ligands for the same chemokine receptor
CCR7 and playing critical roles in recruiting mature dendritic cells from infection site to
lymphatics and T-cell homeostasis, as model chemoattractants. CCL19 stimulation induced
receptor desensitization could dramatically lower receptor occupancy gradients for responding
cells.
Chapter 3 Engineering gradients using polysaccharide
hydrogel microsphere
3.1 Introduction
Through an understanding of fundamental principles of leukocyte trafficking, a variety of
therapeutic applications are being developed, such as vaccine adjuvants, anti-tumor reagents, and
anti-inflammatory treatments [128]. In vaccination and cancer therapy, a promising approach is
to locally engineer chemokine gradients with the goal of drawing immune cells to tumors or
immunization sites. For example, DNA or vaccinia virus vaccines co-injected with DNA
plasmids encoding the chemokines CCL21 or CCL 19 increased the protective immune response
against Herps Simplex Type 1 Virus [129]. Intratumoral injection of leukocyte-attracting
recombinant chemokines, such as CCL21 [130] or CCL16 [131], have shown promising anti-
tumor effects. Intratumoral injection of dendritic cells transfected to express CCL21 [132] or
including CCL21 retroviral particles in adoptive T-cell therapy [133] have shown improved
effects in tumor rejection. The adenoviral delivery of CCL16 synergized with the use of CpG
and anti-IL-10 antibody [134] to promote the accumulation of dendritic cells and macrophages at
tumor sites and elicited cascading innate and adaptive immune responses to reject large tumors.
Biomaterials may have a key role to play in this setting, by providing the means to gain greater
control over engineered chemoattractant gradients relative to transfected cells or bolus attractant
injection. Kumamoto et al. showed that implanted poly(ethylene-co-vinyl acetate) rods releasing
the mature dendritic cell chemoattractant CCL 19 and a tumor antigen could elicit promising anti-
tumor immunity [135]. The immature dendritic cell chemoattractant CCL20 has also been
encapsulated in biodegradable in situ-crosslinking hydrogels comprised of Dextran vinyl sulfone
and reactive polyethylene glycol [136] to attract antigen presenting cells to an injection site
during vaccination. Controlled release materials also offer the potential to engineer gradients for
basic studies of chemotaxis in vitro, such as demonstrated by Kress et al. who used optical
tweezer manipulation of attractant-releasing PLGA microspheres as a strategy to finely position
attractant gradients relative to responding cells [137].
We previously reported the use of poly (lactide-co-glycolide) (PLGA) microspheres
loaded with the chemokine CCL20 or bacterial formyl peptides to generate local dendritic cell
chemoattractant gradients [81]. This system was attractive as it employed a well-established fully
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bioresorbable material for chemokine release, but the loading of chemokines (typical of many
protein cargos in PLGA particles) was limited to on the order of -1 wt% of the microspheres,
and we found that obtaining functional release of many other candidate chemokines of interest
was problematic, likely due to the harsh microenvironment within eroding PLGA particles [82-
84]. Thus, we searched for an alternative system that could more efficiently entrap chemokines
with higher net bioactivity, and provide "point-source" release of a broader range of attractants
to engineer chemokine gradients in vitro and in vivo.
Apropos of this challenge, we recently developed injectable formulations of the well-
known anionic polysaccharide biomaterial alginate, based on mixing alginate aqueous solutions
with suspensions of calcium alginate microspheres; the microspheres served as local sources of
excess calcium that crosslinked the surrounding solution over a period of minutes via ion
exchange [138, 139]. The favorable in vivo properties of these alginate materials and the
structural similarities of alginate to native glycosaminoglycans (GAGs) led us to hypothesize that
alginate microspheres could be utilized not only as ion reservoirs, but also as carriers for
reversible loading and controlled release of chemokines. Chemokines are generally cationic
small proteins (-8-20 KDa), which bind to GAGs in the extracellular matrix (ECM) or on the
surface of cells. Many chemokines bind the sulfated and carboxylic acid residues of heparan
sulfate (HS) and its analogs, in some cases with nM affinity, and proteoglycan binding has been
formally shown to be essential for the in vivo activity of some chemokines [29, 140, 141]. We
reasoned that similar interactions between chemoattractants and acid groups of alginate
microspheres would enable loading/release of chemokines, and the ubiquitous nature of charge-
mediated chemokine binding to matrix would allow this approach to be applied to many host
attractants. Providing support for this concept, alginate has been used to encapsulate many
therapeutic proteins via ionic interactions, such as basic fibroblast growth factor (bFGF) [142],
transforming growth factor-pi (TGF-pi) [90], nerve growth factor (NGF) [143], and platelet-
derived growth factor (PDGF) [144].
Here, we report on studies testing this hypothesis and demonstrating a simple approach to
create chemokine-loaded microspheres that potently chemoattract immune cells for at least 24
hrs in vitro. This system was suitable for loading/release of several chemokines important in
immunity, including CCL19, CCL21, CXCL12 and CXCL10. We employed simulations of the
gradient field generated around individual microspheres coupled with Boyden chamber assays
and direct videomicroscopy imaging of human leukocytes migrating near alginate microspheres
to test the functionality of these attractant particles, and defined conditions for long-lived and
long-ranged attraction of human T-cells or dendritic cells to isolated microspheres or collections
of particles.
3.2 Materials and methods
3.2.1 Materials
LF120M alginates (70-150 mPa s with 45-55% guluronic acid units) were obtained from
FMC Biopolymers (Sandvika, Norway). 2,2,4-Trimethylpentane (iso-octane, ChromAR, 99.5%)
was obtained from Mallinckrodt Baker (Phillipsburg, NJ). Calcium chloride dehydrate,
Sorbitane monooleate (Span 80), Tween 80, HEPES buffer, and lipopolysaccharide (LPS) from
Escherichia coli, lectin from Phaseolus Vulgaris (PHA) were purchased from Sigma-Aldrich (St.
Louis, MO). Bovine type I collagen (PureCol@ stock solutions -3 mg/ml) was obtained from
Advanced Biomatrix (Tucson, Arizona). Human recombinant CCL2 1, CCL 19, CXCL 12, GM-
CSF and detection ELISA Duoset* kits were purchased from R&D systems (Minneapolis, MN).
Mouse CXCL10 and human IL-4 recombinant proteins were obtained from Peprotech (Rocky
Hill, NJ) and mouse CXCL10 detection ELISA kits were purchased from R&D systems. Human
recombinant IL-2 was obtained from Chiron (Emeryville, CA). RPMI-glutamax, Alexa fluor
488 and Alexa fluor 555 small scale labeling kits were purchased from Invitrogen (Carlsbad,
CA). Polydimethylsiloxane (PDMS) rubber culture chambers were cast from Sylgard 184
silicone elastomer kits (Dow Coming, Midland, MI). Low autofluorescence phenol red-free
RPMI powder was obtained from Mediatech (Manassas, VA). Ficoll-paque for lymphocyte
isolation was purchased from GE Healthcare (Uppsala, Sweden). All materials were used as
received unless otherwise noted.
3.2.2 Synthesis of alginate microspheres
Alginate microspheres were synthesized using a procedure we previously reported [138,
139]: Briefly, alginate was dissolved in phosphate buffered saline (PBS) pH 7.4 (1% wt/vol) and
passed through a sterile 0.45 tm syringe filter. The solution (400 pl) was added dropwise and
homogenized at 25'C for 3 min at 8000 rpm (UltraTurrax T25 homogenizer, IKA Works) in 35
ml of iso-octane containing 1.5 ml Span 80 and 0.5 ml Tween 80, and then 25 pl CaCl2 (5%
wt/vol) solution was added dropwise followed by 4 min homogenization. The resulting calcium
alginate microspheres were collected by centrifugation and washing 2X with 35 ml iso-octane
followed by washing 3X with 1 ml deionized water, then stored at a stock concentration of 5x10 6
microspheres/ml in deionized water at 4'C until use.
3.2.3 Characterization of microspheres
The size distributions of alginate microspheres in deionized water were determined using
a Horiba laser scanning particle size distribution analyzer LA-950V2. The morphology of
alginate microspheres was characterized using a Zeiss Axiovert 200 epi fluorescence microscope,
and the number concentration of alginate microspheres was quantitated via a haemocytometer.
3.2.4 Loading of chemokines in alginate microspheres
To determine the net surface charge of candidate chemokines, crystal structures of
chemokines available from the Protein Data Bank were inspected (www.pdb.org, structures:
CXCL12: 2KED; CXCL1O:lLV9) using Star Biochem software (MIT, Cambridge, MA) to
identify surface-exposed residues. For CCL21 and CCL19 whose crystal structures are not yet
available, it was assumed that all charged residues were exposed on the surface, consistent with
many other chemokines [145]. The isoelectric point of the chemoattractants was calculated
based on the published amino acid sequence.
Before use, chemokine was loaded into the alginate microspheres by adsorption: alginate
particle suspensions were spun down, the supernatant discarded, and the particles were
resuspended in a concentrated chemokine solution at 5x106 particles/ml (equivalent to 0.04
mg/ml alginate) for 90 min (except where otherwise noted) on a rotator at 4'C. Chemokine
stock solutions were diluted in PBS with 0.1 wt% BSA for these loading incubations. After the
incubation period, the microspheres were washed 3X with 1 ml phenol red-free RPMI 1640
medium containing 10% fetal calf serum (FCS) to remove unbound chemokine. The chemokine-
loaded particles were then resuspended in phenol red-free RPMI at 5x10 6 particles/ml and used
for release or imaging studies. The amount of chemokine loaded was evaluated by subtracting
the quantity of chemokine detected in the washing supernatant (analyzed by ELISA) from the
total amount of attractant initially added in the loading process. We confirmed that this analysis
gave similar results to measurements obtained by digesting microspheres with alginate lyase (10
ng/ml alginate lyase for 20 min at 37 'C) and measuring the loaded chemokine directly.
3.2.5 Release of chemokines from alginate microspheres
Kinetics of chemokine release from the microspheres were determined by suspending
5x10 4 chemokine-loaded alginate microsphere in 1 ml releasing buffer (as noted in the text) and
incubating at 37 'C on an orbital shaker (200 rpm). At each time-point, the particles were
pelleted, the supernatant collected for analysis, and fresh buffer was added to approximate sink
conditions during release. The amount of chemokine in supernatant samples was measured by
ELISA.
In order to simulate the gradient fields developing around individual microspheres in our
chemotaxis assays, we calculated the apparent diffusion constant for chemokine within
individual alginate microspheres. This effective diffusivity, Deff, was determined by fitting the
measured fraction of chemokine released at each time-point using a short term solution for Fick's
Second Law applied to spherical geometry in sink conditions (valid for time-points when < 40%
of the total release has occurred) [146]:
M,' Det2 3 Dfft
where M is the amount of chemokine release at time t, M, is the total amount released at infinite
time (i.e. total amount loaded in the particles), and wi is the weight fraction of microspheres with
radius Ri, summed over the distribution of all microsphere sizes. This analysis accounted for the
polydispersity of the microspheres and the sum over all particle sizes was carried out using the
experimentally determined size distribution of the particles. Data was fit using the built-in
nonlinear regression algorithm of Prism 5.0 software (GraphPad Software).
3.2.6 Cells
Peripheral blood mononuclear cells (PBMCs) were isolated by ficoll gradient
centrifugation of whole blood or unpurified buffycoats from healthy anonymous donors
(Research Blood Components, Boston, MA). Resting T-cells were isolated by magnetic sorting
(pan human T-cell negative selection kit, Miltenyi, Auburn, CA) and cultured in RPMI-glutamax
(Invitrogen, Carlsbad, CA) containing 10 mM HEPES and 10% FCS for 18 hr prior to use.
Activated T-cells were prepared by culturing PBMCs at 7x10 6 cells in 3 ml RPMI medium with
10% FCS and stimulated with 1 ig/ml PHA for two days. On day 3, activated PBMCS were
ficolled to remove dead cells, followed by magnetic sorting using T-cell isolation kit from
Miltenyi. The purified human T-cells were cultured at 1x10 6/ml in 10% FCS containing RPMI
medium with 100 U/ml IL-2 and used on day 4. To prepare monocyte-derived human dendritic
cells (DCs), monocytes were isolated from PBMCs by magnetic selection (CD14 microbead
positive selection kit, Miltenyi) and then cultured at lx106 cells/ml in RPMI medium containing
25 ng/ml recombinant human IL-4 and 100 ng/ml recombinant human GM-CSF for 7 days to
generate monocyte-derived DCs. Medium was changed every other day; on day 5, 100 ng/mI
LPS was added to mature the DCs, and the cells were used for experiments on day 7. Activated
human T-cells or dendritic cells used for imaging were labeled with 3.3 pM CMTPX (Invitrogen)
prior to experiments according to the manufacturer's instructions.
3.2.7 Preparation of collagen hydrogels
Soluble collagen (3.0 mg/ml stock acid solution) was mixed with 0.1 M sterile NaOH and
iOX phenol red-free RPMI in a 8:1:1 vol ratio to achieve pH 7.2, then this mixture was
combined with FCS (final conc. 10% vol/vol) and phenol red-free RPMI at a ratio of 3:0.33:0.67
to obtain a final collagen concentration of 1.8 mg/ml. This collagen precursor solution was
mixed with cells and/or alginate microspheres at desired concentrations and incubated at 370 C to
allow polymerization of the solution into a fibrillar collagen gel containing the desired
concentration of suspended cells and alginate particles.
3.2.8 Modified Boyden chamber chemotaxis assay
T-cells (5x10 4 cells in 50 pl) in RPMI medium with 10% FCS or 1.8 mg/mi collagen
solution were applied to the top compartment of 96-well polycarbonate filter plates with 5 ptm
pore sizes (Neuro Probe, Gaithersburg, MD); recombinant chemokines or chemokine-loaded
alginate microspheres in RPMI with 10% FCS (30 gl) were added to the lower compartments of
each chamber. CCL21-loaded alginate microspheres (2.5 pg/mg alginate) were loX serial
diluted from 5x10 6 particles/ml (total CCL21 loaded on alginate microsphere was equivalent to
10 pg/ml soluble CCL21) to generate dose titrations. After a 2 or 4 hr incubation at 370 C for
cells added in medium or collagen, respectively, cells remaining on top of the filters were
removed by gentle washing and those that migrated to the bottom chamber were quantified using
a Cyquant cell enumeration kit (Invitrogen) following the manufacturer's instructions.
3.2.9 Microsphere depot videomicroscopy chemotaxis assay
Custom culture wells composed of two interconnected cylindrical wells each -4.5 mm in
diameter and -3 mm in depth were prepared by sealing PDMS rubber molds against #1
borosilicate glass coverslip labtek chamberslides (Nalge Nunc Labtek). Collagen precursor
solution (30 pl) mixed with 5x10 4 alginate particles loaded with 0.8 ptg CCL21 (50% was Alexa
fluor 488-labeled) was deposited in one chamber of the PDMS mold and incubated at 370 C for 5
min, then 30 pil of collagen mixed with CMTPX-labeled LPS-matured dendritic cells at lx106
cells/ml was deposited in the adjoining chamber. The labtek slide was immediately placed in a 5%
C0 2 , 370 C humidified environmental chamber on a Zeiss Axiovert 200 inverted fluorescence
microscope. Samples were imaged in time-lapse, employing a computer-controlled robotic stage
to collect images of 9 adjacent 334 x 448 Rm fields of view at 20X across the interface between
the chemokine-loaded well and cell-loaded well in rapid succession. Brightfield, green and red
fluorescence images were collected from all 9 fields every 5 min for 10 hrs.
3.2.10 Isolated microspheres videomicroscopy chemotaxis Assay
Single custom culture wells containing one cylindrical well (- 4.5 mm in diameter and ~3
mm in depth) were sealed to glass coverslip imaging chambers similarly as described in 2.9.
Collagen precursor solution (30 pl) mixed with activated CMTPX-labeled human T-cells (final
conc., 3x10 6 cells/ml) and chemokine-alginate microspheres (final conc., Ix10 4 particles/ml) was
deposited into the pre-heated culture well and then imaged in time-lapse. One 334 x 448 gm
field containing a single alginate microsphere was selected for imaging in time-lapse in each
sample. Brightfield and red fluorescence images were taken every minute for 3 to 6 hrs.
3.2.11 Isolated microsphere chemokine gradient modeling
The release of chemokines and development of concentration gradient fields around
individual alginate microspheres embedded in collagen hydrogels was simulated by solving
Fick's second law of diffusion for a single attractant-releasing microsphere centered in a cubic
space of dimension a using the transport of diluted species module in COMSOL modeling
software (COMSOL Inc., Burlington, MA). The dimension of the space, a, was taken as the
mean distance between microspheres dispersed within a collagen matrix at a total number
concentration CMs:
-
1/3a = cMS
The COMSOL model solved differential equations for diffusion of chemokine with an initial
uniform concentration of attractant in the beads (C) at time zero and no flux at the boundaries:
= DV 2 C
at
t <0,C=Co,r i RandC=0,r > R
t > 0, no flux at boundary ; D =Dff, r R and D = DC, r > R
where De is the diffusivity of chemokine in collagen and Deff is the effective diffusivity of
chemokine within the alginate microsphere, defined from our experimental measurements as
described in section 2.5 above. Following prior work [81], because the porosity of the fibrillar
collagen matrix is on length scales much greater than the size of the chemokine and we found no
evidence for interactions of the chemokines studied with the type I collagen used here in ELISA
binding assays (data not shown), De was taken as half the diffusivity of chemokine in water, D.
D, was estimated using the empirical relationship [50, 104]:
Do = A
where A is a constant, 2.82x10-5 cm2/s (g/mol)1/ 3, and MW is the protein molecular weight.
These relationships gave DCCcL2 1 = 6.5x10-7 cm 2 /s and DeCXCL 2 = 7.45x1 0-7 cm 2/s. Solutions of
the diffusion equations were solved for free triangular FEM mesh points of maximum spacing, 8
pm and minimum spacing, 16 nm.
As suggested in previous studies [50, 101], the chemokine receptor occupancy (B),
defined as the concentration of receptor with bound chemokine (RC) divided by the
concentration of total receptor on the cell surface (Rma) was calculated by assuming chemokine-
receptor binding reaches equilibrium:
RC CB= K= -
Rmax Kd+C
where Kd is the binding affinity of chemokine and receptor. CCL21 binding affinity for CCR7
has been measured on CCR7-transfected cells or on human T-cells, with estimates ranging from
1 nM to 10 nM [65, 68, 113] and here we chose to use Kd = 5 nM. The affinity between CXCR4
and CXCL12 were reported to be 1.8 nM or 4 nM in [147, 148], and 3 nM was used here. The
receptor occupancy gradient was derived as:
dB Kd dC
dr (Kd +C) 2 dr
3.2.12 Single-cell migration analysis
To analyze cell migration in the two-well conjoined gel chemotaxis imaging assay and
isolated microsphere chemotaxis imaging assay, individual dendritic cells or T-cells were tracked
for the time window indicated in the text using Image J (NIH, Bethesda, MD). The chemotactic
index (CI) was defined as the displacement of each cell in the direction of the attractant gradient
divided by the total path length it traveled over the observation time [59]. In the conjoined gel
chemotaxis assay, an instantaneous chemotactic index (ICI) was determined for the 20 cells
analyzed in the field of view 1 mm away from the interface between the cell source and
attractant source gels. The ICI was defined as the distance traveled by the T-cell toward the
attractant source gel in one increment of observation time (5 min) divided by the total
displacement of the cell in that interval. These single ICI values were averaged over all time
steps to obtain a mean CI for the total 20 cells tracked in each condition.
In the isolated microsphere chemotaxis assay, ICI values were determined for each cell
analyzed at each time point over a 1 hr time of observation, and these values were recorded along
with the starting position of each cell at that time step. To capture the effect of differences in
the chemoattractant gradient as a function of distance from the bead, the ICIs were then binned
in 25 pm intervals of distance of the cell from the bead and ICI values within each bin were
averaged to capture the mean strength of chemotaxis as a function of position in the gradient
over the 1 hr analysis time: i.e. we averaged all ICI values collected for cells 0-25 pm from bead,
25-50 pm away, 50-75 pm away, etc. For cells whose starting position were beyond 200 pm
were binned together and labeled 250 pim.
3.2.13 Statistical analysis
Measured values are expressed as means ± standard errors (SE). Levels of significance
for comparing average CI and velocity of dendritic cells in conjoined gel assay were calculated
using an unpaired two-tailed t test. Level of significance for comparing mean values of ICI of T-
cell migration in isolated microsphere assay to hypothetical value zero were calculated using one
sample t test. Level of significance for comparing mean values of ICI as a function of distance
to microspheres was calculated using paired t tests. All calculations were made using GraphPad
Prism 5.0.
3.3 Results
3.3.1 Chemokine alginate microsphere formulation
To obtain cell-sized alginate particles, we employed a water-in-oil emulsion synthesis
approach we described previously [139, 149] to prepare calcium alginate microspheres: As
depicted in Figure 3.1, an aqueous alginate solution was emulsified in iso-octane with lyophilic
surfactants, and the alginate emulsion droplets were ionically crosslinked by the subsequent
addition of aqueous calcium chloride. The resulting alginate particles had a spherical
morphology (as seen by brightfield microscopy, not shown) and diameters of 31+12 um in the
hydrated state (Figure 3.2A), as measured by laser diffraction.
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Figure 3.1 Schematic of water-in-oil emulsion process for alginate particle synthesis and
loading of proteins to alginate particles.
Chemokines are typically small basic proteins and many are known to bind with
substantial affinity to anionic extracellular GAGs [29, 96, 150, 151]. We reasoned that the
anionic polysaccharide chains within alginate microspheres could serve as surrogates for native
mammalian proteoglycans and provide multivalent binding sites to support reversible loading of
chemokines by adsorption into pre-synthesized alginate particles. We chose human CCL21 (12
kDa, net charge +16) as a model chemokine to study the loading and release of attractants from
alginate microspheres, due to its relevance in immune cell trafficking to lymphatics and
lymphoid tissues [71, 74-77] and its known high affinity for GAGs [123, 152]. As shown in
Figure 3.2B for the particular case of alginate microspheres incubated with a 20 pg/ml CCL21
solution, particles rehydrated with concentrated CCL21 solutions rapidly equilibrated with the
chemokine, and maximal levels of attractant were bound within 30 min. This rapid binding
equilibration is consistent with prior studies where ionic adsorption has been utilized to load
charged proteins in alginate matrices [91]. Using 90 min incubations of particles with
chemokine, as the quantity of protein mixed with particles was decreased from 50 pg CCL21/mg
alginate to less than 10 ig chemokine/mg polysaccharide, the loading efficiency of CCL21
increased from 55% to greater than 95% (Figure 3.2C). Flow cytometry analysis of alginate
microspheres loaded with fluorescently-labeled CCL21 showed uniform shifts of the entire
particle distribution to brighter fluorescence as increasing quantities of CCL21 were added to a
fixed concentration of particles, indicating that the entire population of microspheres contributed
uniformly to chemokine binding (Figure 3.2D). The average attractant loading in individual
alginate microspheres was 16 pg CCL21 per particle (average particle size of 31 pm) for the case
of adding 25 jig CCL21 per mg alginate particles. Scatchard plots of the ratio of bound to
equilibrium free CCL21 vs. bound CCL21 (Figure 3.2E) were concave, suggesting negative
cooperativity in the adsorption process. Consistent with this finding, the adsorption data was fit
well by an empirical Freundlich isotherm model (solid line through the data in Figure 3.2E)
[153], which captures the binding of an adsorbent to multiple sites in a matrix with
heterogeneous binding energy:
y = aC""
where C is the free chemokine concentration in the loading solution, y is the concentration
loaded in alginate microspheres, a is the adsorption coefficient (quantifying the adsorption
capacity) and 1/n denotes the adsorption exponent indicating the adsorption intensity. Using
nonlinear regression we obtained a as 1.349 ± 0.2443 ml/mg alginate, 1/n as 0.8577 ± 0.05307
(quality of fit R square = 0.9972). Similar heterogeneous binding site equilibria and negative
cooperativity in binding have been measured for other protein-ionic matrix adsorption studies
[154].
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Figure 3.2 Characterization of alginate hydrogel microspheres and chemokine loading. (A)
Size distribution of alginate particles determined by laser diffraction. (B) The net amount of
chemokine bound and percentage of added chemokine adsorbed by alginate microspheres
(loading efficiency) were quantified as a function of incubation time for 5x10 6 particles/mi
incubated with 20 pig/mi CCL21 (equivalent to 0.4 jig CCL2 1/mg alginate) up to 24 hrs. (C)
Loading efficiency and net quantity of CCL21 loaded into alginate microspheres incubated for
90 min with varying doses of chemokine. (D) Flow cytometry analysis of microspheres showing
binding of Alexa fluor 555-labeled CCL2l to particles following incubation of microspheres
with indicated Alexa 555-CCL2l doses for 90 mi (E) Scatchard plot of CCL2l adsorption to
alginate microspheres. Data were fit to the Freundlich model for adsorption (solid line). Data
shown are means ±SE.
3.3.2 Kinetics and bioactivity of CCL21 release from alginate microspheres
The kinetics of CCL2 1 release from alginate microspheres was characterized by bulk
measurements of chemokine in the superatant of particle suspensions over time. We first
assessed the impact of medium ionic strength on chemokine release. Consistent with
electrostatic-mediated binding of CCL21 to the alginate matrix, increasing the ionic strength of
the release buffer increased the rate of attractant release from the particles (Fig.2A). Next, we
evaluated the effect of the amount of chemokine loaded on the release rate (Fig. 2B); the net
amount of CCL2 1 released at any time was proportional to the quantity loaded. We fit the
release data over 5 hrs to a model applying Fick's law to a polydisperse collection of
microspheres with the experimentally-determined size distribution to obtain an effective
diffusion constant for chemokine in the alginate matrix [154]. This model fit the data well (Fig.
2C) with Deff = (4.73 ± 0.26) x 10-'3 cm2/s for particles incubated with 25 pg CCL21/mg
alginate during loading. This experimentally-derived Deff provided the means for modeling the
chemokine gradient formed around individual particles (discussed in detail below).
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Figure 3.3 Kinetics of CCL21 release from alginate microspheres. (A) Impact of medium
ionic strength on rate of CCL21 release from alginate particles (particles loaded at 25 pg
CCL21/mg alginate for 90 min) incubated in 10 mM PBS pH 7.4, 2 mM CaCl2, 1% BSA
medium containing the indicated concentrations of NaCl at 370C. (B) Kinetics of CCL21 release
from alginate particles into RPMI medium with 10% FCS at 37'C as a function of quantity of
chemokine added to alginate during loading. (C) Fractional release of CCL21 vs. time fit to a
simple diffusion model (solid line), for particles incubated with 25 pg CCL2 1/mg alginate during
loading. Data shown are means ± SE.
We next used a modified Boyden chamber chemotaxis assay [50] to evaluate the
bioactivity of chemokine released from alginate microspheres for attracting resting human T-
cells. T-cells suspended in medium or fibrillar collagen gels were placed on the top surface of 5
pim-pore membranes, and migration through the filters in response to soluble CCL21 or
equivalent total doses of CCL21 loaded in alginate microspheres in the lower wells was
quantified after 2 hr (for cells in medium) or 4 hr (for cells in collagen). The objective of these
measurements was only to obtain a baseline assessment of whether attractant released from the
microspheres was functional for chemoattraction, since the concentration gradients produced in
this assay by soluble CCL21 are expected to be very different from that generated by the CCL21-
releasing microspheres [81]. As expected [65, 68, 113], soluble CCL21 elicited chemotaxis of
T-cells when added to the lower well of the migration chambers at doses of 10 ng/ml, with
attraction plateauing at 100 ng/ml or higher concentrations for cells in medium (Fig. 3A). When
cells were added to filters in collagen (requiring migration through the collagen matrix to cross
the filters), lower levels of net migration were detected but a similar trend of increasing
migration with increasing CCL21 dose were observed, with a plateau in response at 1 pg/ml
attractant. Importantly, CCL21-releasing alginate particles also triggered dose-dependent
chemoattraction of T-cells in both medium and collagen gels, demonstrating activity of the
released protein (Figure 3.5A). Note that equivalent migration is not expected here both
because of the different gradients generated by soluble attractant vs. microspheres and also
because only 10-15% of the CCL21 is released from the microspheres over these time courses.
100-
so. laItpe control
immature DCs
a 40 mature DCs
00 10 10 10 10
FL4.H:: As47.CCR7
Figure 3.4 Flow cytometry analysis of chemokine receptor expression on human T-cells and
monocytes derived dendritic cells. CCR7 expression on immature DCs and mature DCs (day 7)
that are 100 ng/ml LPS stimulated on day 5.
Sustained cell migration through 3D extracellular matrix is more relevant for gauging the
potential utility of alginate microspheres for engineering chemotaxis in vivo than migration very
short distances through filter membranes [155]. Thus, as a second bioactivity assay we also
measured single-cell migration paths for human dendritic cells (DCs) suspended in collagen gels
and exposed at time zero to an adjacent (physically associated) gel containing either soluble
chemokine or CCL21-loaded alginate microspheres (schematically illustrated in Figure 3.5B).
Maturing DCs in the periphery express CCR7 and migrate to lymph nodes in response to CCL21
produced by lymphatic vessels in the local tissue [32, 156]; we used DCs stimulated with LPS to
trigger CCR7 expression (Figure 3.4) for this assay. 5x1 04 alginate microspheres loaded with a
total of 0.8 pg CCL21 (releasing -0.16 ptg over 10 hr) were introduced in the "attractant source"
side gel at time zero, and migration of DCs in the adjacent "cell source" gel and crossing into the
adjoining gel were tracked for 10 hr by videomicroscopy. DCs exposed to microsphere-
generated gradients showed highly directional migration, as seen qualitatively in the video data
collected (Videos S3.1 and S3.2) and in wind-rose plots of overlaid individual cell paths
compared to DCs in collagen with no attractant present (Figure 3.5C). As shown in Figure 3.5D,
although DCs migrated with similar velocities in the collagen matrix in the presence or absence
of the attractant-releasing microspheres, the cells migrated with significantly greater
directionality toward the attractant source gel in response to microsphere-generated gradients.
Although the release rate of individual microspheres decays substantially over the timecourse of
this assay, sustained DC attraction was observed throughout the 10 hr observation period.
Strikingly, DCs near the attractant source gel at time zero migrated into the region where alginate
microspheres were deposited and showed strong directional attraction right to the surface of
individual CCL21-releasing particles (visualized by labeling DCs with a red cytosolic dye and
loading the alginate particles with a fraction of Alexa Fluor 488-labeled CCL21, Figure 3.5E and
Video S3.3). Thus, despite the presence of a field of overlapping gradients generated by the
large collection of microspheres in the attractant gel, DCs still sensed and responded to local
gradients around individual nearby microspheres. Altogether, these results suggest CCL21
released from the alginate particles was bioactive and strongly chemotactic for both human T-
cells and dendritic cells.
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Figure 3.5 Bioactivity of CCL21 released from alginate microspheres. (A) Percentage of
resting human T-cells migrating through filters in response to different total doses of CCL21
provided in soluble or microsphere form in a modified Boyden chamber chemotaxis assay;
incubations were carried out for 2 hr (cells applied to filter plates in medium) or 4 hr (cells
applied to filter plates in collagen gels). Open bars, soluble CCL2l with cells in medium; black
bars, soluble CCL2 1 with cells in collagen; gray bars, microspheres with CCL2 1 and cells in
medium; hatched bars, microspheres with CCL21 and cells in collagen. (B)-(E) Conjoined
collagen gel chemotaxis assay with LPS-activated human dendritic cells in a "cell source" gel
migrating toward an "attractant source" gel loaded at time zero with 0.8 pig CCL2l in 5x104
alginate microspheres or control gels lacking attractant. (B) Schematic of conjoined gel assay
setup; scale bar is 2 mm. (C) Wind-rose 2D plots of individual DC migration paths tracked 3-6
hr after start of the assay, for cells located 1 mm from the center of the conjoined gel; each track
length is 60 min; x-y axes are cell displacements from their starting position at the beginning of
the time interval in ptm. (D) Average chemotactic index (open bars) and velocity of DCs (filled
bars) (n = 20 cells analyzed for each condition; unpaired t test: ** P<0.000 1). (B) Migrating
DCs (red) entering the "attractant source" gel migrated directly into contact with individual
CCL2 1 alginate microspheres (marked by Alexa-fluor-tagged CCL2 1, green); Lower panels
show zoomed-in view of individual microsphere highlighted by the dashed box in upper panel
series; scale bar is 50 pim.
3.3.3 Loading and sustained release of homeostatic and inflammatory chemokines from
alginate microspheres
To be generally useful, this chemoattractant delivery approach should be capable of
loading/releasing many different chemokines of interest for targeting different immune cell types.
We thus tested the loading of several other host-derived attractant molecules in alginate
microspheres, including CCL19, CXCL12, and CXCL1O. CCL19, a second homeostatic ligand
for CCR7, is expressed in lymph nodes [157, 158], and has a non-redundant role in lymphocyte
homing [159]. CXCL12 is a lymphoid chemokine that attract T-cells, B-cells, and other immune
cells [160], and CXCL10 is an IFN-y-induced chemokine highly expressed at inflammatory sites,
which attracts activated effector T-cells to sites of infection [161, 162]. As summarized in Table
3.1, these attractants have similar molecular weights, but differ in their net charge and net
surface-exposed charge. For comparison with CCL21 loading/release from alginate particles, we
measured the loading efficiency for two different attractant loading concentrations (Figure 3.6A),
and then measured release into serum-containing medium over time (Figure 3.6B). The
hierarchy of chemokine loading into the alginate particles was inverse to the release rate:
CXCL12 loaded to the highest levels in the particles but also released extremely slowly from the
particles. Although this remains a limited dataset, we found that for these four chemokines, the
logarithm of the effective diffusivity of each chemokine in alginate (obtained by fitting the
release data to a Fick's law model as in Figure 3.3C) correlated well with the net surface charge
of the proteins per residue Figure 3.6C), consistent with charge-mediated interactions between
the attractants and alginate matrix dominating the loading/release behavior. These data suggest
that alginate particles may be useful for engineering attractant gradients with a range of different
candidate chemokines, though attractants with a very high surface charge density (e.g., CXCL12)
may be bound too tightly for effective gradient generation when loading into unmodified, highly
charged alginate.
Table 3.1. Chemokine physicochemical properties
CXCL12 CCL21 CCL19 CXCL10
Molecular weight (kDa) 7.96 12.25 8.80 8.70
Net charge +9 +16 +7 +9
Isoelectric point 10.3 10.5 10.1 10.5
Surface positive charge +13 +25 +13 +13
Surface negative charge 0 -9 -6 -5
Net surface charge per residue 0.19 0.14 0.09 0.10
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Figure 3.6 Loading and release of CXCL12, CCL19 and CXCL1O from alginate
microspheres. (A) Loading efficiency of chemokines in microspheres was measured following
incubation of 2.5 or 25 ig chemokine/mg alginate for 90 min. (B) Kinetics of chemokine release
into serum-containing medium at 37'C for particles incubated with 25 pg chemokine/mg
alginate during loading. (C) Logarithm of effective diffusivity of chemokines in alginate as a
function of net surface charge per residue, with best fit linear regression. Data shown are mean
±SE.
3.3.4 Chemotaxis responses to isolated chemokine-releasing microspheres
The experiments shown in Figure 3.5B-E are a useful in vitro model of chemoattraction
of cells to a site of particle deposition in tissue, as might be used in immunotherapy or
vaccination. However, the striking local attraction of DCs to individual microspheres observed
in these experiments prompted us to examine more closely the chemoattraction elicited by
isolated individual microspheres, as a model for the response of leukocytes to isolated
chemoattractant-releasing cells acting as a point source of chemokine. To this end, we first
sought to measure and/or predict the concentration profiles of attractant generated around
individual alginate microspheres loaded with CCL2 1. We first tried to directly visualize
gradients around individual particles in collagen gels using fluorescently-labeled CCL21 as a
tracer, but the minimum concentration of Alexa dye-labeled CCL21 that could be detected above
background by either our widefield or confocal microscope systems was ~200 ng/ml, well above
the concentration for chemotaxis observed in our collagen migration assays (data not shown).
Thus, we instead used bulk measurements of chemokine release rates from collections of beads
in suspension to model and predict the gradient expected around individual microspheres in
collagen.
We simulated concentration fields evolving around individual microspheres using a 2D
axis-symmetric model in which a microsphere was embedded in an 500 pm space (modeling
alginate particles suspended in collagen at a concentration of 1x10 4 microspheres/ml); the
chemokine was given an effective diffusivity in the alginate matrix Deff as determined from our
experimental bulk release data (e.g., Figure 3.3C), while the diffusivity of chemokine in fibrillar
collagen was taken as half its diffusivity in water [50, 104] (see Methods). From the chemokine
concentration profiles, we also calculated the receptor occupancy gradient for cells located at any
position along the chemokine gradient, as it the receptor occupancy gradient that determines
signaling and directional migration [103].
The predicted concentration profiles and receptor occupancy gradients over time and
space for a 50 pm diameter alginate particle initially loaded with 40 pg CCL21 (mimicking the
loading achieved for incubations of 25 pg CCL21 per mg alginate) are plotted in Figure 3.7A, B.
The rapid diffusion of released CCL21 [50, 104] quickly dispersed chemokine throughout the
simulation volume (Figure 3.7A), while the decaying rate of chemokine release from
microspheres over time led to chemokine concentration gradients (and thereby receptor
occupancy gradients) that slowly decayed over the simulated timecourse (Figure 3.7B). Prior
studies [101, 112] have shown that leukocytes can sense and orient in response to a 2% change in
chemokine concentration across the cell body (~10 pm) at optimal concentrations near Kd, and
the threshold receptor occupancy difference for robust chemotactic migration has been estimated
to be ~10 receptors across the length of a cell. This corresponds to a 0.033 - 0.1% change in
receptor occupancy across the cell body for a lymphocyte expressing 10, 000 - 30, 000
chemokine receptors. Comparing the predicted receptor occupancy gradient to this threshold
(expressed by the gray shaded area as a range covering physiological receptor expression levels,
Figure 3.7B), we see that over the first few hours the microsphere-generated gradient provides a
detectable chemotactic stimulus for cells more than 150-200 prm away from the source. The
model also predicts that by 5 hours, although the gradient has decayed at longer distances, a
functional chemotactic gradient remains at distances 75-125 pLm or less from the source. For
comparison, we also modeled the concentration profile and receptor occupancy gradient
evolution for CXCL12-releasing particles. For the same attractant loading conditions modeled
above (25 ig CXCL12/mg alginate), the concentration gradient of CXCL12 (Figure 3.7C)
developing around an individual microsphere was very shallow (less than 1% per 10 jim).
Further, the receptor occupancy gradient was only beyond the estimated threshold within 50 jim
of the microsphere surface (Figure 3.7D).
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Figure 3.7 Relationship between microsphere-generated chemoattractant gradients,
receptor occupancy, and migration responses. (A-D) Simulated chemokine concentration
gradients developed around an isolated 50 jm-diameter alginate microsphere releasing CCL21
(A, B) or CXCL12 (C, D), calculated from experimentally-determined release rates of particles
incubated with 25 pg chemokine/mg alginate during loading. Shown are the chemoattractant
concentration (C) (A, C) and chemokine receptor occupancy gradients (dBldr) as a function of
distance to the surface of microsphere (r) (B, D) at 15 min, 0.5 hr, lhr, 2hr, 3hr, and 5hr; arrows
indicate the trend of increasing time. Shaded areas in B, D indicate the estimated threshold of
gradients in receptor occupancy required for directional migration for cells expressing 10, 000 to
30, 000 receptors.
4.2-
44L40-
C m
To test whether this simple analysis of chemokine receptor engagement could accurately
predict lymphocyte migration responses to chemokine-releasing microspheres, we imaged the
response of activated T-cells to isolated CCL21- or CXCL12-releasing alginate microspheres in
collagen gels, using experimental conditions matching as closely as possible the modeled
conditions. Human T-cells were activated with PHA and IL-2; these cells expressed both
CXCR4 and CCR7 (Figure 3.8). As shown in Figure 3.9A, activated T-cells suspended in
collagen gels with CCL21-releasing alginate particles were attracted to individual microspheres
from up to nearly 200 pm away. In the first hour, the mean chemotactic index (averaged values
of the displacement of a given cell over a 1 min time interval toward the nearest particle divided
by the total displacement) was on average greater than zero (indicating migration toward the
nearest bead) for cells 150 pim or closer to attractant beads, and increased monotonically as the
distance from the cell to nearest bead source decreased. After 4 hours, a similar trend of
increasing chemotactic index with decreasing distance to the nearest bead held, but cells greater
than 125 pm from the nearest bead exhibited a mean ICI which was not statistically different
from zero. Thus, in line with the predictions from the simulation, the strength of the attractant
gradient decayed and contracted around the microsphere over this 5-hr timecourse. By contrast,
CXCL12-releasing alginate microspheres showed much weaker chemoattraction of T-cells, with
some chemotaxis detected in the first hour, but no attraction by the second hour of observation
(Figure 3.9B). Thus, the simulations correctly captured the chemotaxis response of T-cells
responding to CCL2 1-releasing particles, but did not predict the behavior of cells migrating near
CXCL12-releasing microspheres. This outcome likely reflects the reductionist nature of the
model employed here, which neglected receptor internalization and other modes of receptor
desensitization that could be important for CXCL12-CXCR4 signaling.
A 00B 100
80- 80
$ 40 40-
20 20
0. 0
0 ;2 3 0 I 2 3
10 1 10 100 10 0 1 02 10 10
PL4.4:: Alexa647-CCR7 FU-H:: PE.CXCR4
Isotype control Isotype control
resting T-cells resting T-cells
activated T-cells activated T-cells
Figure 3.8 Flow cytometry analysis of chemokine receptor expression on human T-cells and
monocytes derived dendritic cells. (A) CCR7 expression on human resting T-cells and
activated T-cells (day 4). (B) CXCR4 expression on human resting T-cells and activated T-cells
(day 4).
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Figure 3.9 Mean chemotactic index (CI) of activated human T-cells migrating through
collagen gels in the vicinity of isolated microspheres releasing CCL21 (A) or CXCL12 (B) as
a function of distance from the microspheres (r); shown are mean CI ± SE determined from 1-
min time steps of cells analyzed in the indicated window of time after start of the experiment;
dashed lines indicate the expected CI for random migration (zero); values significantly different
from zero are indicated: * P<0.5, ** P<0.00L, *** P<0.0001. CIs determined for (E) n = 107
cells (0-1 hr) and n = 45 cells (4-5 hr); * P<0.05; (F) n = 67 cells (0-1 hr) and n = 59 cells (2-3
hr); * P<0.05.
3.4 Discussion
Chemokines control lymphocyte trafficking in health and disease, and are interesting
candidates for therapeutic manipulation in vaccines and cancer immunotherapy. We previously
showed that chemokines encapsulated in PLGA particles could create more sustainable and in
some cases steeper chemoattractant concentration gradients within ECM gel models of tissue
matrix compared to bolus soluble chemokine injections [81]. Here we sought to develop a more
facile microsphere release system with greater control over the range of chemokines that could
be functionally encapsulated and the dosages of attractant that could be loaded. We found the
physical and chemical properties of alginate hydrogels particularly attractive in this setting: (i)
The high hydrophilicity provides an environment that will preserve the bioactivity of
encapsulated molecules; (ii) alginates form hydrogels under very mild gelation conditions
permitting in situ loading of biomolecules if desired [89]; (iii) alginate has been used to carry
70
cells and cytokines for therapeutic use due to its advantages of biocompatibility and mild
processing conditions [89, 163]; and finally (iv) the anionic polysaccharide structure acts as a
surrogate of extracellular GAGs to mimic reversible chemoattractant binding to the ECM.
Based on these considerations, we developed a post-synthesis adsorption approach to load
chemoattractants into alginate microspheres, which provided several advantages over seeking to
entrap chemokines during the particle preparation: Small single-use batches of attractant-loaded
particles could be prepared, allowing efficient use of recombinant proteins; the attractants were
not exposed to high shear or organic solvents used in the particle preparation; and a single
homogeneous preparation of microspheres could be used for many independent experiments.
Testing several different human chemokines, we found that these basic proteins could be loaded
to high levels in alginate particles, with release rates predicted by their net surface charge.
Overall, loading/release measurements were consistent with a dominant role for electrostatics in
mediating binding of the chemokines studied here to the alginate matrix, similar to binding of
these largely cationic factors to GAGs in native ECM.
Cellular secretion rates for chemokines have been measured to range from 10-8 to 10-6
ng/hr/cell [118, 119]. However, these measurements are usually based on bulk measurements
taken after prolonged culture periods of 24 or 48 hrs; while some chemokines are constitutively
secreted, others are produced rapidly after stimulation within a brief time window (15 min - 1 hr)
[164] and so these in vitro measurements may underestimate the production rate of chemokines.
The maximum rates of cytokine secretion fall in the range of 2300-8000 molecules/cell s [92]
(estimated to be 1.65-5.74x10~4 ng/cell-hr for CCL21). Here we found that alginate
microspheres loaded with the human chemokines CCL21, CCL19, CXCL12 and CXCL1O
released these attractants at rates ranging from 7.2x10-6 - 3.2x10-3 ng/hr/paritcle, covering the
physiological range of chemokine release by individual cells. For CCL2 1, CCL 19, and CXCL 10,
release rates in the physiological range were maintained for at least 24 hrs (data not shown).
We used modified Boyden chamber assays and direct videomicroscopy analysis of cells
migrating in collagen to assess the bioactivity of alginate-released chemokines, and found in both
assays evidence of potent chemoattraction elicited by particle-released chemokine. The striking
attraction of dendritic cells to individual alginate microspheres in the conjoined gel assay
prompted us to explore in more detail cell migration near individual cell-sized attractant sources.
The ability to experimentally define (and manipulate) the attractant release rate from these
microspheres provides the opportunity to dissect how immune cells interpret local attractant
gradients in a manner that would be challenging to achieve using live cells as chemokine sources.
We analyzed the migration response of activated T-cells toward microspheres releasing CCL21
or CXCL12, as these two attractants were distinguished by moderate and very slow release
kinetics, respectively. Because direct visualization of chemokine gradients proved to be
problematic, we used measurements of chemokine release coupled with careful characterization
of the microsphere size distribution (because particle size influences the rate of chemokine freed
at the particle surfaces) to provide experimental data guiding simulations of attractant gradient
evolution around isolated microparticles. The modeling semi-quantitatively predicted the
responsiveness of T-cells to CCL21-releasing microspheres, with the chemoattracting "reach" of
the microspheres initially drawing in cells from nearly 200 pm away, but collapsing toward the
source particle slowly over the course of hours. By contrast, T-cell migration toward CXCL12-
releasing microspheres was transient, with chemotaxis of cells up to 125 im away at the start of
the experiment but no attraction detected after 1 hr. The simple diffusion-based modeling of the
CXCL12 gradient predicted that some attraction should have been sustained near the beads. The
good agreement of responses seen for CCL21 and relative lack of agreement for the model with
CXCL12 migration data likely reflects the key difference in receptor biology for these two
ligands; CCL21 bound to CCR7 does not trigger receptor downregulation or desensitization [117,
165], while CXCL12 triggers rapid receptor internalization [166, 167]. The loss of receptors
from the cell surface raises the effective threshold in receptor occupancy that must be met for
directional migration, likely ablating chemotaxis for cells in CXCL12 gradients over time.
For some applications, it would be desirable to modulate the release rate of individual
chemokines independent of the quantity of attractant loaded. Several strategies could provide
this level of control: (i) varying the density of alginate or calcium content in the hydrogel
microspheres [168]; (ii) adding additives that alter protein binding [90]; or (iii) derivatizing
carboxyl functional groups on the alginate chains to alternate functional groups that could exhibit
enhanced or reduced binding [169]. The flexibility of tuning release properties of chemokines
from alginate microspheres would make it a further attractive method of delivery chemokines for
therapeutic use and chemotaxis studies.
3.5 Conclusions
The development of versatile chemoattractant carrier systems is of interest for both
therapeutic applications and fundamental chemotaxis studies. Here we have shown that alginate
hydrogel microspheres can be efficiently loaded with a range of different chemokines and release
bioactive protein generating functional attractant gradients both in 2D medium and 3D collagen
ECM gels. We have also demonstrated the use of chemokine loaded alginate microspheres as
model attractant "point sources" to investigate the chemotaxis behavior of activated human T-
cells and showed that a simple diffusion-based modeling of the concentration profile and
resulting receptor occupancy gradient could predict chemotactic behavior for an attractant
receptor which does not undergo internalization/desensitization. We thus believe that this
alginate hydrogel microsphere system could be useful in in vitro and in vivo chemotaxis studies,
and possibly in immunotherapy and vaccine delivery by attracting target effector cells to desired
tissue sites. More generally, attractants involved in developmental, wound healing, and tissue
regeneration processes could be delivered using this approach to engineer chemotaxis of many
cell types in vitro and in vivo.
Chapter 4 Regulation of Leukocyte Single-cell Dynamics by
Local and Regional Chemokine Gradients
4.1 Introduction
Chemoattractants stimulate a broad range of cellular migration responses in vivo. Intravital
and whole-tissue explant imaging studies have shown that abundant CCR7 ligands stimulate T-
cell motility in lymph nodes [76, 78], but migration paths in the lymph node appear largely
random, guided by haptokinetic interactions with the chemokine-decorated stromal reticular
network [24, 156]. Directional migration can also be stimulated by chemoattractants in vivo, as
has been directly observed for lymph node B-cells migrating toward the T-cell area during
immune responses [79], CD8* T-cell recruitment to antigen-specific CD4* T-cell/DC pairs in
lymph nodes [170], or neutrophils chemotaxing through tissue to sites of Leishmania infection
[171]. "Swarming" behaviors of T-cells aggregating around antigen presenting cells in lymph
nodes [172, 173] and neutrophils aggregating around parasite-infected cells in skin [171] or
lymph nodes [174] have also been described, which likely involve host- or pathogen-derived
attractant signals. However, because the nature of the chemoattractant concentration fields in live
tissues in vivo is typically unknown, the mechanisms by which chemoattractant production,
diffusion, matrix binding, and receptor stimulation integrate to elicit such a diversity of
responses remain poorly understood.
Few studies have directly visualized chemotactic migration of T-cells or dendritic cells
under conditions where the attractant gradient is known/well defined. Current theoretical and
experimental evidence suggests that mammalian cell chemotaxis is elicited in the presence of
chemoattractant gradients as cells detect ARe, the difference in the number of chemokine-
receptor complexes induced at the front vs. rear of the cell [5, 102, 103]. Strikingly, the
threshold value of AR, required for leukocytes to sense a gradient has been has been estimated to
be as small as ~10 receptors over the length of a cell [102], and very shallow attractant gradients
stimulate chemotaxis [103, 175]. Recently, microfluidic devices have been developed that permit
the generation of stable, linear or near-linear one-dimensional concentration gradients of
chemoattractants, in order to expose cells within mm-scale 2D or 3D migration chambers to
well-defined attractant stimuli [58, 176]. These studies have shown that lymphocytes and DCs
are responsive to extremely shallow chemoattractant gradients, and have revealed hierarchies in
responsiveness for leukocytes exposed simultaneously to competing gradients [52, 175, 177].
However, the concentration gradient of attractants formed in proximity to an isolated secreting
cell [92] qr collection of cells [81] is highly nonlinear, with rapid decay in concentration with
distance from the secreting source(s). Thus, cells migrating toward a chemokine-releasing cell
face both increasing attractant concentration and increasing gradient steepness. Increasing
concentrations may suppress the cells' ability to respond to the gradient through receptor
saturation and desensitization, while increasing gradient steepness should promote increased
directionality to chemotactic migration by increasing the gradient in receptor engagement across
the cell body. These two competing effects make it unclear how leukocytes will respond as they
approach secreting cells generating physiologically-steep attractant gradients, and whether
chemokine signaling alone in the absence of additional cues in the environment can promote
migration of leukocytes into contact with target secreting cells or temporally-stable retention of
cells at a location in space. Microfluidic devices are not well suited to address these problems as
they typically create only one-dimensional gradients, and do not capture the "point source"
nature of individual secreting cells.
To address these fundamental questions, we employed a reductionist in vitro experimental
system combined with computational modeling to mimic the production of chemoattractants in
tissue and characterize the response of human leukocytes to these well-defined locally-produced
gradients. We designed synthetic hydrogel microspheres with sizes on the order of single cells,
which can be loaded with chemokines and release these attractants over a period of many hours
at physiologic rates, mimicking secretion by single cells, described in Chapter 3. Here, we
embedded these "artificial secreting cells" (ASCs) in 3D extracellular matrix gels with human T-
cells or DCs, and quantitatively analyzed single-cell dynamics of cells responding to individual
chemokine sources as a function of the type of attractant, ASC secretion rate, ambient chemokine
concentration, and chemokine source density. These measurements revealed that leukocyte
chemotaxis is strongly correlated with the chemokine receptor occupancy difference induced
over the responding cells. T-cells exhibited an all-or-none response to soluble attractant
gradients, either committing to the gradient and migrating highly directionally to the source or
ignoring the gradient completely; increasing chemotactic responses for stronger gradients
reflected increasing numbers of cells recruited into the responding population. Strikingly, under
conditions of low receptor desensitization, stable stimulatory gradients stimulated long-lived
swarming of T-cells or DCs around individual attractant-releasing beads. However, high
densities of attractant sources, where the ambient attractant concentration is high and
neighboring gradients overlap lead to short-lived attraction toward individual sources and biased
"hopping" between attractant sources. Together, these results provide substantial insight into
how diverse migration responses can be elicited by any given chemoattractant depending on the
quantitative conditions of attractant production in a local tissue.
4.2 Materials and methods
4.2.1 Cells
Peripheral blood mononuclear cells (PBMCs) were isolated by ficoll gradients from
unpurified buffycoats of healthy anonymous donors (Research Blood Components, Boston, MA).
Resting T-cells were isolated by magnetic sorting (pan human T-cell negative selection kit,
Miltenyi, Auburn, CA) and cultured in RPMI-glutamax (Invitrogen, Carlsbad, CA) containing 10
mM HEPES and 10% FCS for 18 hr prior to use. Activated T-cells were prepared by stimulating
PBMCs with 1 pg/ml PHA for 2 days. On d 3, stimulated PBMCS were ficolled to remove dead
cells, followed by magnetic sorting and culture for 1 d with 100 U/ml IL-2 (Chiron, Emeryville,
CA) before use on d 4.
To prepare dendritic cells (DCs), monocytes were isolated from PBMCs by magnetic
selection (CD14 positive selection kit, Miltenyi) and cultured with 25 ng/ml IL-4 (Peprotech,
Rocky Hill, NJ) and 100 ng/ml GM-CSF (R&D systems, Minneapolis, MN) for 7 d to generate
monocyte-derived DCs. Medium was changed every other day; on d 5, 100 ng/ml LPS was
added to mature the DCs, and the cells were used for experiments on d 7. To prepare activated
murine T-cells, splenocytes from C57B1/6 mice were cultured in 2 pg/ml Concanavalin A (Con
A) (Sigma Aldrich, St Louis, MO) and 1 ng/ml IL-7 (Peprotech) for 2 d, then resuspended with
100 U/ml IL-2 for 2 days. Cells were used on day 4 after ficoll removal of dead cells; flow
cytometry analysis confirmed a purity of> than 90% T-cells (data not shown).
All cells used for imaging were labeled with 2.5 pM CellTracker red CMTPX (Invitrogen)
prior to experiments according to the manufacturer's instructions.
4.2.2 Artificial secreting cell preparation
Alginate bead ASCs with a mean size of 30 pm diam. were prepared as described in
Chapter 3. ASCs were loaded with chemokines at doses as noted in the text by resuspending
beads in solutions of attractant for 1 hr to allow binding to the alginate, followed by washing
with PBS to remove unbound protein, and then used immediately. To visualize the ASCs
loaded with unlabeled CCL19, we used alginate beads encapsulated with 0.05% 200 nm green
fluorescent amine-nanoparticles (Invitrogen).
4.2.3 Videomicroscopy chemotaxis assay
Collagen precursor solution (30 ptl) composed of bovine type I collagen (PureCol@ stock
solutions -3 mg/ml was obtained from Advanced Biomatrix (Tucson, Arizona)) was mixed with
CMTPX-labeled cells (final conc. 3x1 06 cells/ml) and chemokine-loaded ASCs and deposited
into pre-heated chambered coverglasses (Nalge Nunc Labtek, final collagen conc. 1.8 mg/mL)
and immediately placed in a 5% CO 2, 374C humidified environmental chamber on a Zeiss
Axiovert 200 inverted fluorescence microscope. Fields of view containing single or multiple
ASCs were selected and imaged in time-lapse at 20X. A brightfield image and a red
fluorescence z-stack (80 pm in depth centered on the focal plane, with 4.2 [tm steps in z) was
collected every 1 min (5 min for DCs) for up to 10 hrs. 80 [im z-stack green fluorescence
images were taken before and after time-lapses to indicate the location of the ASC microspheres.
4.2.4 Single-cell migration analysis
Single cell migration paths from the imaging data were tracked in 3D for the time window
indicated in the text using Volocity 5.2 image analysis software (PerkinElmer, Waltham, MA).
To evaluate chemotaxis, we calculated two parameters: (i) approach angle is the angle between
CK gradient and the direction of the movement, with 0* to be perfectly aligning with gradient,
900 is perpendicular to gradient and 1800 to be perfectly away from gradient; (ii) The
chemotactic index (CI) was defined as the displacement of each cell in the direction of the
attractant gradient divided by the total path length it traveled over the observation time [59]. An
instantaneous chemotactic index (ICI) was determined here for each cell analyzed at each 1-
minute time interval over a 1.5 hr time of observation. The CI and ICI take values of 1 for cell
tracks perfectly aligned with the chemoattractant gradient and -1 for perfectly antiparallel to the
gradient. In addition to chemotactic parameters, velocity and turning angle (angle between each
movement step) were calculated. All these values were recorded along with the starting position
of each cell at that time step.
In some instances, to capture the effect of differences in the chemoattractant gradient as a
function of distance from the bead, instantaneous cell migration parameters were binned based
on the position of each cell in 25 pm intervals of distance from the cell to the nearby bead, and
the values within each bin were averaged to capture the mean strength of chemotaxis as a
function of position in the gradient over the 1 hr analysis time: i.e. we averaged all the values
collected for cells 0-25 pm from bead, 25-50 im away, 50-75 pm away, etc. Cells whose starting
positions were beyond 200 im were binned together and labeled 250 p1m.
The hit rate, Ko,, was defined as the number of T-cells migrating into contact with a
particle per unit time normalized by the total number of cells in the imaging volume Nt,,:
Kon = number of contacts [170]. By taking a ratio of KO, to the theoretical hit rate for lymphocytes
time-Ntot
encountering ASCs by chance during random migration through the matrix, Ko'nn, we obtained
a convenient measure of the degree of directional migration, with K"o > 1 indicating biased
migration toward the chemokine sources. Korn can be calculated using a simple 3D random
collision model as previously derived [178]: Korand = w (rT + rM)2VT, where rT is the radius of
the ASC, rM is the contact radius of the cells with ASCs (15 im) and VT is the average velocity of
the cells.
Analyses of cells that migrated away from a microsphere and were "recaptured" by the
gradient were conducted using Image J (NIH, Bethesda, MD).
4.2.5 Statistical analysis
Measured values are expressed as means ± standard errors (SE). Levels of significance for
comparing groups were using two-tailed nonparametric Mann-Whitney test. All calculations
were made using GraphPad Prism 5.0.
4.3 Results
4.3.1 Differences in receptor desensitization lead to distinct responsiveness of lymphocytes to
CCL21 vs. CCL19 gradients
We designed an experimental system to mimic CCR7 ligand production in tissue in order
to test whether the predictions made by the simple receptor binding/desensitization model
described in Chapter 2 correctly portray leukocyte responses to local CCL21 and CCL19
gradients, and to determine the relationship between the magnitude of AR, and actual migration
responses. We prepared artificial secreting cells (ASCs), cell-sized synthetic polysaccharide
microspheres that release chemoattractants at tunable rates, to create cell-mimetic CCL19 and
CCL21 gradients in vitro. ASCs were composed of the polysaccharide alginate, which was
loaded with chemokines by adsorption, mimicking the reversible binding of chemokines to
polysaccharides in ECM (Figure 4.1A-D) as described in detail in Chapter 3. When placed in
cell culture media, ASCs released chemokine at physiologic rates over 10-20 hr, with the release
rate determined by the quantity of attractant loaded in the particles (Figure 4.1E).
We embedded ASCs in three-dimensional type I collagen ECM gels with resting human T-
cells, and tracked the response of lymphocytes to locally-evolving chemoattractant gradients by
videomicroscopy. Because CCL19 and CCL21 were active at concentrations (<5 nM) well
below the limits detectable by our fluorescence microscopes (-16 nM), direct visualization of
gradients generated around individual ASCs in ECM gels by fluorescence imaging was not
possible. Instead, we measured rates of attractant release from collections of microspheres in
suspension and used this data combined with the measured size distribution of the microspheres
to calculate the expected attractant diffusion profile around individual beads (see Chapter 3).
Via ELISA measurements, there was no detectable binding of CCL19 or CCL21 to type I
collagen (Figure 4.2) (consistent with prior reports [175]) and no significant chemokine
degradation over 12 hrs in collagen with 10% serum (Figure 4.3). Therefore, for calculations of
in vitro gradients generated in the ECM gels, we assumed no matrix binding or attractant
degradation.
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Figure 4.1 Characterization of chemokine loaded alginate bead as ASC. (A) Chemical
structure of alginate composed of D-Mannuronic acid and L-Guluronic acid units. (B) Post-
loading scheme: adsorption of chemokine into alginate beads. (C) bright field micrograph of
alginate beads. (D) Alexa-488-labeled CCL21 loaded alginate beads, demonstrating adsorption
of chemokine by the alginate matrix. (E) Initial release rates (over 0.5 hr) of CCL19 and CCL21
from alginate beads as a function of chemokine loading. Data shown are mean ± SE.
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Figure 4.2 CCL21 and CCL19 do not bind to type I collagen. (A-B) Optical densities of
matrix-bound chemokine relative to the background (only blocked with serum). This
measurement was conducted by coating ECM proteins or glycosaminoglycans on ELISA plates
overnight at 4'C, blocking with fetal bovine serum (FBS) for 2h at 25*C, then incubating with
0.3 pg/ml CCL21 (A) or CCL19 (B) for 1 h at 25'C. Matrix-bound chemokine was then
detected using biotinylated antibody and streptavidin-HRP. The ratio >1 indicated specific
binding and less than 1 indicated non-specific binding. Data were presented as mean ± SE.
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Figure 4.3 No degradation of CCL21 and CCL19 in type I collagen gels. Soluble CCL19 or
CCL21 was incubated in 1.8 mg/mL collagen hydrogels or complete medium for 12 hrs at 37 *C
and the quantity of chemokine remaining was assayed by ELISA. Shown is the ratio of the
amount of remaining CCL19 or CCL21 in collagen to that in medium presented as mean ± SD
from triplicate samples; In medium, ~ 70% of chemokines were detected with ELISA detectable
bioactivity after 12 hour incubation at 37 *C.
As shown in Figure 4.1E, ASCs loaded with -2-50 pg CCL21 or CCL19/mg alginate
effectively mimicked the physiological range of single-cell chemokine secretion rates (0.01-1
pg/hr/cell, as discussed in Chapter 2). Thus, the calculated chemoattractant profiles and receptor
occupancy gradients generated around individual CCL21-releasing beads (Figure 4.4A-C) were
qualitatively similar to those predicted for secreting cells in tissue (compare Figure 2.3D with
Figure 4.4C), with above-threshold receptor occupancy differences expected up to -150 pm
from individual ASCs. Notably however, the lack of chemokine clearance/degradation in this in
vitro model leads to slow decay of the receptor occupancy gradients over a period of hours as
chemokine builds up in the matrix (Figure 4.4D and Figure 4.5). In contrast, for CCL19-
releasing ASCs, gradient modeling predicted that lack of attractant clearance would elicit
pronounced receptor desensitization as chemokine accumulated in the ECM gel, with weaker
ARc values decaying to sub-stimulatory levels after a few hr, and functional gradients extending
much shorter distances from the source bead (Figure 4.4D-G). Notably, increasing release rates
lead to steadily increasing receptor occupancy differences for CCL21-releasing beads (as
quantified by the value of AR, at the gradient source, Figure 4.6A), while receptor
desensitization leads to a predicted peak in strength of the gradient at intermediate chemokine
release rates for CCL19 (Figure 4.61).
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Figure 4.4 Concentration gradient characteristics developed around single CCL21-ASCs or
CCL19-ASCs at varying releasing rates. (A, E) Chemokine concentration profiles, (B, F)
Fraction of occupied receptors and (C, G) Receptor occupancy gradients as a function of distance
from the ASC surface; (D) Temporal receptor engagement gradient at ASC surface for CCL21
and CCL19.
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Figure 4.5 Time evolution of
CCL21-ASC at releasing rate of
of 0.05 pg/hr/particle.
concentration and receptor occupied fraction profile. (A)
0.7 pg/hr/particle at density. (B) CCL19-ASC at releasing rate
To assess the relationship between these different patterns of receptor occupancy and
functional migration responses, peripheral blood human T-cells were imaged migrating in
collagen for 30 min in the presence ASCs "secreting" CCL19 or CCL21 at each of the of release
rates modeled in Figure 4.4, and migration paths were analyzed at the single-cell level. To
quantify T-cell responses, we measured mean velocities of the cells (vmean) and a hit rate ratio
Kan. The hit rate was defined as the number of T-cells migrating into contact with a particle per
Kon
unit time normalized by the total number of cells in the imaging volume N,r: Kon =
number of contacts [170]. By taking a ratio of Kon to the theoretical hit rate for lymphocytes
time-Ntot
encountering ASCs by chance during random migration through the matrix, Kon (see methods),
we obtained a convenient measure of the degree of directional migration, with K >Krand
indicating biased migration toward the chemokine sources.
Consistent with the slightly greater sensitivity of human T-cells to CCL19 compared to
CCL21 [115], CCL21-releasing ASCs did not stimulate migration speeds above the level of T-
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cells alone in collagen for release rates less than ~0.2 pg/hr/bead (Figure 4.6C), while CCL19-
releasing ASCs stimulated migration even at the lowest release rate tested (0.01 pg/hr/bead,
Figure 4.6D). Though migration speeds of T-cells plateaued at -8 Im/min for higher
chemokine release rates in the presence of both CCL19- and CCL21-releasing beads, the hit rate
ratios showed distinct patterns of chemotactic responses to CCR7 ligand gradients: Increasing
CCL21 "secretion" rates from ASCs triggered increasing hit rates for migration of T-cells to
nearby ASCs (Figure 4.6E), while the hit rate ratio of T-cells migrating toward CCL1 9-releasing
ASCs peaked at the intermediate chemoattractant release rate of -0.05 pg/hr/particle (Figure
4.6F). As a control, T-cells embedded in collagen with "empty" ASCs in the presence of uniform
concentrations of soluble CCL21 or CCL19 migrated with similar velocities but showed a hit
rate ratio that was not significantly different from 1, indicating random migration (Figure 4.6 A-
F). As expected, T-cell migration toward the attractant sources was dependent on G protein-
coupled receptor signaling and CCR7, as treatment of cells with pertussis toxin or blocking anti-
CCR7 antibodies dropped the hit rate ratio -1 (Figure 4.7). For each chemokine, the strength of
the receptor occupancy gradient correlated with the magnitude of chemotaxis detected (Figures
Figure 4.6A, C and Figure 4.6B, D). Notably, the peak chemotactic responses elicited by
optimal CCL19 gradients and CCL21 were comparable, but CCL19 gradients stimulated this
response at -10-fold lower AR, (Figure 4.6G), which may reflect the more sensitive engagement
of downstream signals (such as phosphorylated ERK [117]) by CCL19. These findings suggest
that the strength of chemotactic responses to both CCL 19 and CCL21 gradients are linked to the
magnitude of receptor occupancy differences generated across responding lymphocytes, but that
CCL19 engages CCR7 with a lower threshold ARc required for directional migration compared
to CCL21-CCR7 complexes.
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Figure 4.6 Receptor desensitization leads to distinctive T-cells response to CCL19 vs.
CCL21 attractant gradients generated by ASCs. (A, B) Receptor occupancy differences at the
ASC surface at t = 30 min as a function of varying release rate. (C, D) Hit rate ratio, ,.n andKrandKon
(E, F) Mean velocity measured over 30 min after initiation of culture of T-cells with CCL21 and
CCL19 ASCs. (G) Hit rate ratio as a function of receptor occupancy gradient. Data in (C-G) are
shown as mean ± SE.
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Figure 4.7 Increased encounter frequency with CCL21-ASC is CCL21 dependent. (A)
Mean velocity and (B) Hit rate ratio of resting T-cells that are attracted to CCL21 loaded alginate
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beads with release rate of 0.7 pg/hr/particle after cells were treated with pertussis toxin (PTX) or
pertussis toxin B subunit (PTXB) as previously [80] or blocked with 10 Ig/ml CCR7 Ab or
isotype control Ab for 30 min at 4 'C and also 10 ig/ml corresponding Ab during imaging
culture.
4.3.2 Individual T-cells commit to physiologic chemoattractant gradients in all-or-none
fashion
As shown in Figure 2.3, the gradient generated by cells secreting chemokines at a constant
rate is characterized by a temporally stable but spatially-varying concentration and gradient
steepness- both the absolute concentration and the relative slope of the concentration profile
increase on approach toward an attractant-secreting cell. Using ASCs releasing CCL21 to
approximate this idealized tissue model over several hours, we next analyzed how T-cells located
at different distances from chemokine-releasing beads responded to the attractant, and examined
changes in the migration behavior as they moved "up" or "down" the gradient. Migration paths
of resting T-cells within 250 pm of single CCL21-releasing ASCs (release rates 0.7 pg
CCL21/bead/hr) or control beads were analyzed over 1.5 hr. When resting T-cells were imaged
in collagen in the presence of empty beads and a uniformly-dispersed dose of 10 pg/mL soluble
CCL21 to stimulate random migration, migration paths of the cells followed persistent random
walks distributed around individual beads (Figure 4.8A and Video S4.1). By contrast, T-cells in
the vicinity of ASCs releasing CCL21 at 0.7 pg/hr (which elicited peak hit rates in our short term
imaging assays) chemotaxed from distances up to 200 Pm directly into contact with the surfaces
of the attractant-releasing beads, with many cells exhibiting highly directional migration paths
(Figure 4.8A and Video S4.2). From these imaging data, we calculated the approach angle
(angle between the cell's displacement vector and a vector from the cell to the bead),
instantaneous chemotaxis index (ICI, distance traveled toward the bead divided by total distance
moved in a single time interval), turning angle (angle between subsequent displacement vectors
in two sequential time steps), and velocity of each cell at each timepoint. Mean values
determined for all cell/time-point measurements collected at a given distance from the
chemokine source showed that T-cell velocities and turning angles were only weakly dependent
on the cell's position within the gradient, but the mean approach angle steadily decreased and
mean ICI increased as the distance to the source decreased (Figure 4.8B-E). Compared to the
control samples where T-cells were incubated with empty beads in the presence of uniform
concentrations of CCL21, the approach angle decayed steadily as cells came closer to ASCs,
reaching a minimum of ~25' near bead surfaces (Figure 4.8C), while the mean ICI steadily
increased toward a peak value of ~0.5 reflecting highly directional migration toward the
attractant source near the bead surfaces (Figure 4.8B).
To better understand the response of chemotaxing cells at the single cell level, we further
analyzed the probability distribution of ICI as a function of distance to the surface of ASCs. The
2D heat maps shown in Figure 4.8F illustrate ICI distributions across the range of -1 to 1 as a
function of the distance of a given cell from the ASC. The ICI distribution for resting T-cells in
the absence of a chemoattractant gradient is uniformly distributed through the range of -1 to 1
independent of distance to the surface of ASCs. By contrast, it is clearly observed that the
probability distribution of ICI values both for resting T-cells and activated T-cells shows a
population of cells migrating with high ICI values; this population increases in frequency as the
distance from the ASC decreases, i.e. with increasing chemotactic signals generated by the near-
bead gradient. Two distinct scenarios could lead to the probability distribution shown in Figure
4.8F: (i) A subpopulation of cells is responding to the gradient, and each cell in this responding
population becomes more highly directional as it moves along its chemotactic journey toward the
source of chemokines ; (ii) responding cells are highly directional in their migration wherever
they are in the gradient, and closer to the ASC an increasing fraction of cells join this responding
highly chemotactic population. By examining the migration paths of cells in Figure 4.8A, we
noticed a population of cells that were obviously highly chemotactic (with ICI>0.5), even with
starting positions more than 150 im from the source, while some cells were migrating randomly
from the beginning. This observation suggested to us that the monotonically-increasing average
chemotactic response with decreasing cell-source separation did not reflect a uniformly
increasing chemotactic response from the whole population of cells near each ASC. Rather,
individual T-cells exhibited a binary response: either committing to the gradient completely,
with steady highly directional motion up the attractant gradient to the point of contact with the
bead, or alternatively, ignoring the gradient completely and showing random motility patterns.
We thus hypothesized that the chemotactic response of T-cells begins with a stochastic decision
process, where with increasing chemotactic signal strength, the probability of T-cells commit to
the gradient would increase.
To test this idea, we further analyzed the proportion of cells that eventually migrated into
contact with the chemokine source as a function of their start position (Figure 4.8G), the trend
indicates that more cells commit to chemotaxis when their path begins closer to the bead, where
the strength of the receptor occupancy gradient is greater. We defined the chemotactic
coefficient, CC, as the fraction of time cells migrated with an ICI > 0.5, to evaluate the cell
chemotactic fidelity. Shown in Figure 4.8H, the cells that eventually reached the chemokine
source have a mean CC = 0.75, which is much higher than that of the cells that did not migrate
into contact with the source (mean CC = 0.42, p < 0.0001). By contrast, all the cells in the
uniform chemokine field (with no gradient present) have an even lower mean CC = 0.35. This
comparison confirmed the hypothesis if T-cells make decisions to chemotaxis to source from
onset they would highly probably continue to commit all the way with positive feedback. As
shown in Figure 4.81, defining "responder" cells as those that have made contact with ASCs, we
see that the CC for responders or non-responders did not depend on their starting location in the
gradient. Cells that were stimulated to respond to the gradient migrated with a high CC value
even if their stating position was far from the ASC, supporting the hypothesis that the behavior
of individual cells involves a binary all-or-none decision to commit to the gradient or largely
ignore the chemokine stimulus.
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Figure 4.8 Single cell migration dynamics of T-cells to CCL21-ASC. (A) Path plots of
individual resting T-cells near a single ASC (located in the center of the field of view, in the
presence of a uniform field of 10 ptg/mL CCL21 around an "empty" ASC (left) or responding to
an ASC releasing CCL21 at 0.7 pg/hr/bead (right): the top panel show cells starting from more
than 100 pm away and the bottom panels are for cells starting from less than 100 pm away from
the bead; Dashed black circle indicates the location of alginate microspheres; blue solid circle
indicates the start of cell migration path; red indicates ICI>0.8; yellow: 0.8>ICI>0.6; magenta:
0.6>ICI>0.4; blue: 0.4>ICI>0.2; green: 0.2>ICI>O; black: ICI<0. (B-E) Migration parameters
measured by averaging instantaneous values for individual cells as a function of distance to the
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surface of the source and averaging data points collected from different cells located at a given
distance from the bead. (B) Instantaneous chemotactic index; (C) Approach angle; (D) Turning
angle, and (E) Normalized velocity. Resting T-cells to empty microsphere (blue open triangle, n
= 61 cells), resting T-cells to CCL21-microsphere (red open circle, n = 122 cells) and activated
T-cells to CCL21-microspere (purple open square, n = 87 cells). Data are shown as mean values
± SEM. (F) 2D heat map of probability distribution of ICI of cell moves as a function of
distance to the surface of microsphere, r. (G) Fraction of cells that eventually migrate into
contact with the nearest ASC as a function of their starting position. (H) Chemotactic coefficient
of cells with or without gradients. Data are shown as box mean with max/min. (I) Chemotactic
coefficient of responder (open circle) and non-responder T-cells (solid circle) as a function of
their starting position. Data are shown as scatter plot with mean ± SEM indicated.
We also analyzed the migration response of activated human T-cells, to determine whether
primed T-cells with high constitutive motility exhibit similar chemotactic responses to CCL21 at
the single-cell level. T-cells activated in vitro with PHA and IL-2 retained CCR7 expression
identical to resting T-cells (Figure 3.8). Interestingly, activated T-cells responded more strongly
than resting cells to CCL21 gradients, with higher ICI values and lower approach angles
achieved at all positions in the local gradient (Figure 4.8A-G and Figure 4.9). However, primed
T-cells appeared to show the same threshold receptor occupancy requirements for gradient
sensing, with cells up to ~175 pm away from an isolated CCL21 source capable of responding to
the gradient with a non-zero chemotaxis index.
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Figure 4.9 Migration path plot of activated T-cells to CCL21-ASC. (A) starting position >
100 pm. (B) starting position < 100 pim. Dashed black circle indicates the location of alginate
microspheres; blue solid circle indicates the start of cell migration path; red indicates ICI>0.8;
yellow: 0.8>ICI>0.6; magenta: 0.6>ICI>0.4; blue: 0.4>ICI>0.2; green: 0.2>ICI>0; black: ICI<0.
4.3.3 Persistent localized gradients of CCL21 induce swarming of attracted leukocytes
Although chemotactic cell migration is commonly assayed over short durations of 30-60
minutes [49], leukocytes are exposed to persistent attractant sources in vivo (e.g., lymphatic
endothelial cells and lymphoid stromal cells constitutively producing CCR7 ligands [10, 121,
179]), which could stimulate cells over much longer durations. We thus next asked how the
migration response of lymphocytes to persistent CCR7 ligand gradients evolves over time.
Exploiting the lack of desensitization of CCR7 in response to CCL21 binding that permitted
functional CCL21 gradients to be sustained for many hours even under conditions where no
attractant clearance occurs (Figure 4.10D), we imaged resting T-cell migration for 6 hrs near
isolated ASCs releasing CCL21 at 0.7 pg/hr/cell. Strikingly, within 90 min of mixing T-cells and
CCL21-releasing ASCs in collagen, the strong chemotactic response led the vast majority of
cells (~80%) to accumulate around the nearest attractant microsphere (Figure 4.10A, B). This
accumulation reflected persistent "swarming" of attracted lymphocytes around individual ASCs,
where cells that reached a CCL21-releasing bead maintained a high velocity but their direction
remained pinned at the bead surface over many hours (Figure 4.10C, D and Video S4.3).
Swarming required a gradient of attractant, as no accumulation was observed when cells were
mixed with beads in uniform concentrations of CCL21 or when attractant was absent (Figure
4.10C, D, and data not shown). By labeling a fraction of the cells, we could follow individual
cells swarming at beads and found that the mean retention time of individual T-cells around a
CCL21-releasing ASC was ~3 hrs, though strikingly, a population of lymphocytes (~10%) were
attracted to beads and remained localized at a single attractant source for the duration of the
imaging experiment (6 hrs, Figure 4.10E). Those T-cells that did begin migrating away from the
surface of a CCL21-releasing bead were efficiently "recaptured" by the gradient, with ~80% of
cells that began migrating away from the attractant source against the gradient turning and
migrating back to the bead surface, reaching a median distance from the bead of only -50 ptm
before returning to the nearby CCL21 source (Figure 4.10F-H).
As expected from the gradient and receptor desensitization calculations, in contrast to
CCL21, ASC-generated CCL19 gradients were completely unable to support sustained
accumulation of lymphocytes (Video S4.4). Using ASCs releasing CCL19 at rates that elicited
the peak chemotactic response in short term assays (52 fg/bead/hr), T-cells were observed to
transiently chemotax toward CCL19 sources over -30 min, but then migrated away in random
directions at later times (Figure 4.10A), and though T-cell motility remained high, a significant
trapped population failed to develop around CCL19-releasing ASCs (Figure 4.10B-D). This
result correlated with a much lower retention time of T-cells attracted toward CCL19 beads
(statistically different from chemokinetic migration induced by uniform chemokine
concentrations but -10-fold lower than that measured for CCL21 gradient fields) (Figure 4.10E)
and a much lower fraction of cells departing a CCL19-releasing bead surface that were
recaptured by the gradient (Figure 4.10G).
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Figure 4.10 Non-desensitizing CCL21 gradients elicit persistent chemotaxis and swarming
of lymphocytes around isolated chemokine sources, while CCL19 gradients elicit only
transient cell attraction. (A) Path plots of individual cells around CCL21 (top) and CCL19
(bottom) bead; dashed circle indicates the location of chemokine-ASCs; blue solid circle
indicates the start of migration path and red solid circle indicates the end of migration path. (B)
Snapshots or (C) Time-integrated histograms of cell positions around CCL21-releasing
1
microspheres (r = distance from bead surface), obtained by recording the position of each cell in
the field of view at each time-step from 0 to 90 min (n > 300 total cells and 5 microsphere
sources analyzed per condition). (D) Dynamic evolution of T-cells trapped near the surface of
microsphere (30 pim) over 6 hours. (E) Formation of swarms around CCL21 microsphere; scale
bar is 50 tm. (F) Retention time measured the capability of chemokine microsphere retaining T-
cells. (G-I) T-cells swarming in response to a CCL21 ASC (0.7 pg CCL21 released/hr/bead)
were monitored by videomicroscopy for 3 hrs, and the behavior of "escaping" cells that migrated
at least 20 ptm away from the bead surface against the gradient was characterized: (G) Migration
paths of single T-cells illustrating "recapture" of escaping cells. Dimension of gridboxes is 100
pm in x and y. (H) Mean frequency of escaping T-cells recaptured by a CCL21 gradient over a
total imaging period of 3 hrs. (I) Histogram of maximum distance recaptured T-cells migrated
away from the ASC before turning and returning to the local chemokine source.
To determine if the ability of CCL21 gradients to support localized swarming was specific
to T-cells or rather a more general property of CCL21 -CCR7 signaling, we also characterized the
migration response of CCR7-expressing LPS-matured human monocyte-derived dendritic cells
to both gradients. As shown in Figure 4.11 and Video S4.5, human DCs expressing CCR7
exhibited stable accumulation and swarming around CCL21 gradient-generating ASCs. Next, we
asked whether the swarming response triggered by CCL21 gradients could be elicited by other
chemokine/receptor pairs with less pronounced receptor desensitization than CCL19/CCR7.
CXCL1O is an inflammatory chemokine that binds CXCR3 on activated T-cells, and this
chemokine triggers less pronounced downregulation of its receptor when compared to CCL19
[180]. Calculations of CXCR3 receptor occupancy gradients over time predicted that CXCL10-
releasing ASCs would exhibit receptor engagement gradients intermediate between
CCL21/CCR7 and CCL19/CCR7, which should be capable of eliciting sustained chemotactic
responses (Figure 4.12A, B). We tested this experimentally using CXCR3+ activated murine T-
cells (Figure 4.12C) and CXCL1O-loaded ASCs: Consistent with the modeling results, in
response to ASC-generated CXCL1O gradients, activated T-cells swarmed around localized
CXCL10 source for more than 10 hr (Figure 4.12D, Video S4.6). Altogether, these data suggest
that sustained chemokine secretion is capable of promoting both prolonged attraction of
responding leukocytes and dramatic confinement of attracted cells near the attractant source,
provided that receptor desensitization and the steady-state gradient properties permit an above-
threshold AR, to be maintained over time. This dependence on receptor sensitivity leads to
profound differences in the response of lymphocytes to sustained CCL21 vs. CCL19 gradients
when the ambient concentration of attractant is high, despite similar affinities for their ligand and
similar early chemotactic responses in the first 10-20 minutes of attractant exposure.
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Figure 4.11 Activated dendritic cells persistently swarming around CCL21-ASCs. (A)
CCR7 expression on LPS-matured (activated) dendritic cells. (B) Dynamic trapped fraction
evolution (0-5 hr) of mature dendritic cells around CCL21-ASC at releasing rate of 0.7
pg/hr/particle and empty bead; these were averaged over one bead.
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Figure 4.12 Activated murine T-cells persistently swarming around CXCL10-ASC. (A)
Snapshot at t = 30 min of concentration and receptor engagement gradient profile of CXCL 10-
ASC at the releasing rate of 1.7 pg/hr/particle and 0.3 pg/hr/particle. (B) Dynamic evolution of
concentration and receptor engagement gradient profile around CXCL1O-ASC at releasing rate
of 1.7 pg/hr/particle. (C) CXCR3 expression on activated murine T-cells (activated by Con A at
2 pg/ml and IL-7 at 1 ng/ml for two days and then stimulated with 100 U/ml IL-2 for two days
before use). (D) Mean velocity and dynamic trapped fraction evolution (0-1.5 h) of activated
murine T-cells around CXCL1O-ASC at releasing rate of 1.7 pg/hr/particle and empty bead.
4.3.4 T-cells interpret both the gradient and absolute concentration of chemoattractant in their
migratory response to CCL21
Our calculations of gradient formation in Section 2.3.4 showed that even in tissues with
high densities of secreting cells (such as primary and secondary lymphoid organs), local
gradients around individual source cells should lead to chemotaxis-inducing receptor occupancy
differences in nearby lymphocytes (Figure 2.7). However, if above-threshold ARc values always
induce chemotaxis and subsequent "trapping" as shown above for isolated attractant sources, T-
cells would be very inefficient at scanning APCs in lymphoid microenvironments; this is counter
to the known rapid scanning behavior of T-cells in lymph nodes at steady state [181]. Yet as the
ambient steady-state concentration of chemoattractant increases in the local microenvironment,
the increase in overall receptor occupancy will stimulate chemokinesis in competition with
directional migration responses. To determine the impact of the absolute level of chemokine in
the local environment on chemotactic responses and trapping by local gradients, we
systematically varied total chemokine levels by adding increasing concentrations of free CCL21
to the collagen matrix along with CCL21 -releasing beads. We first calculated the gradient
generated around ASCs at a density of 8x10 3 beads/cm 3, releasing CCL21 at 0.7 pg/hr/bead, as a
function of increasing levels of free attractant pre-existing in the matrix. As illustrated in Figure
4.13, at any given timepoint, as the background concentration of free attractant increased,
receptor occupancy increases at all points in the gradient, and the receptor occupancy difference
in responding cells AR, steadily decays. However, the calculations predict that for ambient
concentrations of free CCL21 up to 20 nM (250 ng/mL), -4-fold above the Kd of CCL21-CCR7
binding, T-cells should still be capable of chemotaxing when they come within -50 Pim of a
CCL21-releasing bead for several hours (Figure 4.13B, C). However, in the presence of still
higher concentrations of free CCR7 ligand, the receptor occupancy gradient will be below the
threshold to achieve any directional migration toward the attractant source.
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Figure 4.13 Concentration profile developed around individual CCL21-ASCs with varying
ambient concentration of soluble CCL21 in the field. CCL21 concentration profiles and
resulting receptor occupancy differences were calculated for CCL2 1-ASCs (attractant release
rate of 0.7 pg/hr/particle) at ambient CCL21 concentration, varying from 10 ng/ml to 1 pg/ml
indicated in the label: (A) CCL21 normalized concentration, (B) Fraction of occupied receptors
and (C) Receptor occupancy gradients as a function of distance from the bead surface. (D)
Temporal evolution (15 min to 2 hrs) of receptor occupancy gradients for the presence of 100
ng/ml ambient CCL2 1. (E) Surface receptor occupancy gradients as a function of time at
varying CCL2 1 ambient concentration.
Experimentally, resting T-cells mixed with CCL2 1-releasing ASCs together with varying
concentrations of "free" CCL2 1 showed similar velocities irrespective of the level of free CCL2 1
present (Figure 4.14A). However, the hit rate ratio for T-cells encountering ASCs dropped
monotonically as the concentration of free CCL2 1 increased from 10 ng/mL to 10 pg/mL,
reaching the hit rate expected for completely random migration at 1 pig/mL CCL21 (Figure
4.14B). Mirroring the calculated changes in the shape of the receptor occupancy gradient
profile with increasing free attractant concentration (Figure 4.14B), analysis of the ICI of T-cells
migrating near CCL21-releasing beads over a 90 min period showed a contraction in both the
maximum distance from an ASC where chemotaxis was triggered and the magnitude of the
chemotactic index achieved as the concentration of free attractant in the matrix increased
(Figure 4.14C): Chemotaxis was detected within 50 pm of CCL2 1-releasing ASCs in the
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presence of 100 ng/mL free CCL21, but no attraction was detected for 1 ptg/mL free CCL21.
The retention time analysis showed T-cells attracted to the chemokine source significantly
dropped with increasing ambient CCL21concentration (Figure 4.14D). Up to 100 ng/ml
ambient CCL21, T-cells persistently attracted around chemokine source within the time window
of experiment (90 min). The analysis of the fraction of T-cells trapped by ASC gradients showed
that T-cell swarming persisted in the presence of low levels of background attractant (10 ng/mL
free CCL21), but the fraction of cells localized at the bead surfaces dropped as the ambient
CCL21 concentration was increased (Figure 4.14H, J). Interestingly, activated T-cells
responded to CCL21 concentration gradients more sensitively than resting T-cells, retaining
persistent (> 60 min) swarming responses to ASC-generated gradients in the presence of 10-fold
higher background CCL21 levels (up to 500 ng/mL) (Figure 4.14H, J). Thus, T-cells can detect
local gradients of CCL21 produced by nearby cells even in the presence of substantial
background levels of free attractant in the local microenvironment. However, both swarming
and chemotaxis decay as the ambient chemokine concentration increases.
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Figure 4.14 T-cells could still sense CCL21 gradient in the presence of substantial
background CCL21. (A) Scattered plot of velocity of individual tracks in the presence of
background chemokines indicated in the axis label. (B) Hit rate ratio of resting T-cells in the
presence of uniform background chemokine with the concentration indicated in the axis label.
(C) Average chemotactic index of resting T-cells toward CCL21-microsphere binned on the
basis of distance to microsphere surface. 0, n = 61 cells; 10 ng/ml, n = 55 cells; 100 ng/ml, n =
41 cells; 1 pg/ml, n = 53 cells; 10 pg/ml, n = 111 cells; the random migration chemotactic index
0 was indicated by a dash line. (D) Fraction of resting T-cells (left) and activated T-cells (right)
trapped around CCL21 -microsphere in the presence of background chemokines. (E) Snapshots
of T-cells responding to CCL21 -microsphere in the presence of background CCL2 1. Top: resting
T-cells; Bottom: activated T-cells; Scale bar is 50 pim.
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4.3.5 Overlapping CCL21 gradients trigger a transition from "swarming" around isolated
attractant sources to "hopping" between local gradients
As the density of attractant-secreting cells in a tissue increases, the sharp gradients
produced within 100-200 pim of individual cells will begin to overlap. At such high densities of
attractant-secreting cells (as expected for example in lymph nodes), lymphocytes migrating even
a few cell diameters away from one source will detect the increasing gradient toward another
nearby source, which might lead to transient, sequential chemotactic responses as cells move
from source to source. Alternatively, high overall receptor occupancy achieved in this setting
might elicit an overwhelming chemokinetic signal triggering unbiased, random migration, as
observed above in the case of high levels of "background" attractant. To determine which of
these situations prevails in the setting of a dense field of chemokine sources releasing attractant
at physiologic rates, we varied the mean separation between CCL21-releasing ASCs dispersed
stochastically in collagen. Using ASCs releasing CCL21 at the rate triggering peak chemotaxis
for isolated beads (0.7 pg/bead/hr), we measured the response of T-cells to several different
densities of CCL21 sources, starting from a maximum separation of 500 ptm between sources.
As before, we first calculated the expected concentration profiles and receptor occupancy
profiles as a function of chemokine source separation (Figure 4.15). ASCs as close as 70 pLm
apart were predicted to induce stimulatory AR, values in responding cells close to a given bead
(Figure 4.15C), qualitatively similar to the situation predicted for dense chemokine sources in
tissue (Figure 2.7). However, we chose to image T-cells mixed in collagen with dense CCL21-
releasing ASCs over only the first 60 min, as buildup of chemokine in the in vitro system is
predicted to cause steady decay of AR, over a period of several hours (Figure 4.15 D, E).
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Figure 4.15 .Concentration profile developed around individual CCL21-ASCs with
varying densities in the field. CCL21 concentration profiles and resulting receptor occupancy
differences were calculated for CCL21-ASCs (attractant release rate of 0.7 pg/hr/particle) at
different densities, varying spacing between ASCs of 50 pm, 100 pm, 200 pm and 500 Pm
indicated in the label: (A) CCL21 normalized concentration, (B) Fraction of occupied receptors
and (C) Receptor occupancy gradients as a function of distance from the bead surface. (D)
Temporal evolution (15 min to 2 hrs) of receptor occupancy gradients for the case of 200 Pm
between beads. (E) Surface receptor occupancy gradients as a faction of time at varying ASC
spacing.
We first conducted imaged human T-cell migration responses to CCL21-loaded alginate
microspheres with an average separation of 100 pm in collagen. As a control we characterized
cell migration behaviors using empty alginate microspheres at similar density in the presence of
uniform soluble CCL21 in collagen gels. With the presence of local chemokine gradients around
individual source beads, cells made more frequent encounters with CCL21 loaded alginate
microspheres than with empty unloaded alginate microspheres surrounded by uniform fields of
CCL21, as measured by the hit rate ratio (Figure 4.16). As shown in Figure 4.17A-D,
comparing T-cell migration responses for several different bead densities in collagen, the
encounter rate of T-cells with individual beads was reduced as the bead density increased
(Figure 4.17A). However, for all bead densities tested, histograms of cell positions showed
biased positioning of T-cells nearer to beads than expected for randomly-distributed ASCs
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(Figure 4.17B). As bead density increased, the time that T-cells were spending around
individual CCL21 source steadily decreased (Figure 4.17C); at higher bead densities, lack of
prolonged trapping around a single bead meant that a single cell would have higher chance to
visit serial CCL21 sources (Figure 4.17D-E).
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Figure 4.16 Local chemotaxis to individual beads still exists in dense field of CCL21-ASCs.
Hit rate ratio for the resting T-cells cultured with either CCL21-ASCs or empty beads (in the
presence of 10 ptg/ml CCL2 1) in field of 100 pm spacing between beads within 90 min of onset
of imaging.
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Figure 4.17 Local chemotaxis present in collection of microspheres and still can increase
contact frequency of T-cells. (A) Hit rate ratio of T-cells to individual CCL21-microsphere
among collection of beads with the average bead separation indicated by the x-axis label. (B)
Histogram of tracked cell positions binned on the basis to microsphere surfaces averaged over 90
min for start of imaging. (C) Retention time of individual cells spent on individual microspheres.
(D) Histogram of the number of microspheres that single cells "visited" in 90 min. (E)
Representative cell tracks illustrating how individual cells navigated among multiple CCL21-
microspheres.
As we showed previously that activated T-cells and mature dendritic cells are more
sensitive to CCL21 gradient than resting T-cells, we wondered if the swarming behavior would
persist at ASC densities where swarming of resting T-cells is inhibited. Strikingly, scored by the
intensity of fluorescence around sources, we observed swarming of activated T-cells even at very
high ASC densities (mean separation between beads of 50 pm, Figure 4.18 and Video S4.7).
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Figure 4.18 Activated T-cells still could swarm around individual sources in dense fields of
CCL21-ASCs. (A) Activated T-cells and formed swarms around densely packed CCL21-
microspheres suspended in collagen with a mean separation of 50 pm between beads. Scale bar
is 50 Pm. (B) Trapped activated T-cell fraction around collections of beads. #1-5 indicates the
individual CCL21-ASCs quantified in imaging volume and total indicates the summed result
from individual ASCs.
4.4 Discussion
In this chapter, we examined how the receptor occupancy differences expected in
responding leukocytes would be able to predict cellular chemotaxis responses, without
considering the details of downstream signaling, an approach suggested by previous studies of
the governing factors in chemotaxis [5, 43, 45]. We showed in Chapter 3 that the receptor
occupancy gradient could well predict the chemotaxis of human activated T-cells to CCL21
loaded alginate beads but had some level of discrepancy in response to CXCL1 2-loaded alginate
beads since CXCL12 can desensitize its receptor CXCR4 and induce internalization and
degradation of desensitized CXCR4 [182]. Here we applied a simple mechanistic model to
account for chemokine receptor desensitization to analyze receptor engagement gradient. Since
it is the actual receptor number difference between the front and rear of the cells that translates
into a chemotactic signal, we chose to use the actual receptor number engagement gradients to
predict chemotactic responses.
Recent studies employing microfluidic devices to generate stable, well-defined chemokine
concentration gradients have allowed quantitative analysis of T-cell and dendritic cell migration
in response to well-defined gradients of CCL19, CCL21, or CXCL12 [52, 175, 177]. These
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studies demonstrated apparent differences in the sensitive of leukocytes to CCR7 ligands, and
hierarchies of responsiveness to these three chemokines when cells are exposed to competing
soluble/matrix bound gradients of these factors. We also showed here that CCL19 was more
sensitive compared to CCL21 although it has a similar affinity for CCR7. More interestingly,
human T-cells showed dramatic differences in response to similar concentration gradients: T-
cells could chemotax to CCL21-ASCs and persistently swarm around CCL21 sources for over 6
hr but only transiently chemotaxed toward CCL 1 9-ASCs due to drastic CCR7 desensitization by
CCL19 ligation. Further, CXCL1O-ASCs could induce persistent swarming over 10 hr although
CXCL10 induces moderate CXCR3 desensitization.
Adding uniform concentrations of "background" chemokines in the ASC system made it
possible to tune the sensitivity of T-cells to the gradient created by ASCs in a different way. By
increasing the background chemokine concentration, the concentration gradient was decreased
and thus also the receptor engagement gradient. The chemotaxis and swarming around
individual CCL21 -ASCs were inhibited by high levels of background CCL2 1. This behavior was
consistent with CCL19-microsphere induced T-cell attraction. Although the mechanism was
different in these two cases, the predicted receptor occupancy gradient was similarly low. We
have also observed that T-cells were attracted to CCL21-ASCs and dynamically swarming
around the source in the matrigel (data not shown) where CCL21 can actively binding to the
proteoglycans present [100].
Phenomena similar to the swarming of T-cells around CCL21-ASCs or CXCL1O-ASCs
shown here have also been observed in physiological settings using in vivo imaging models [171,
174, 183], although the responsible chemoattractants were not identified in these studies.
Neutrophils were forming transient and small swarming or persistent and large swarming around
parasite infection sites in lymph node [174] and neutrophils also form swarms around sand fly
infection sites in the skin [171]. Memory T-cells migrated more rapidly than naive cells,
engaged in stable and prolonged conjugates with parasite infected cells and formed swarms [183]
in the subcapsular region of lymph nodes as antigen-specific CD4* T formed stable interactions
with antigen-pulsed dendritic cells in the T-zone of lymph node for more than 10 hr [184, 185].
Similarly, in a "Hill" like gradient generated using microfluidic devices, neutrophils were found
to accumulate around the peak during a 60 min imaging window [58].
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Our analysis of T-cell migration responses to bead-generated gradients suggests that the
commitment to chemotaxis is a binary decision for individual cells. With increasing chemotactic
signals, the probability of T-cells to make the commitment to chemotaxis increases. Instead of
becoming gradually more chemotactic during migration, T-cells make decision from onset, in an
all-or-none fashion. In van Haastert's work [186] studying the relationship between cell
chemotactic responses and chemokine gradients, they found that at the lower detection limit of
chemokine gradients cell migration is random walk biased by stochastic fluctuations on
chemokine-receptor interaction. With increase of chemotactic signals, the probability of the cells
that have more receptor bound in the front than the back would increase correspondingly and this
would lead to more chemotactic cells. Their analysis supported our findings: (1) On single cell
level, individual cells make stochastic decision based on the probability of detecting chemotactic
signal correctly; (2) On population level, proportion of cells that make correct chemotactic
decision increases with the strength of chemotactic signals.
4.5 Conclusion
Chemoattractants regulate diverse immunological processes, but how cell migration
patterns are shaped by attractant production in tissues remains enigmatic. Using computational
modeling and "artificial secreting cells" (ASCs), cell-sized chemokine-releasing beads, we
analyzed leukocyte migration in physiologic gradients of CCL21, CCL19, or CXCL10 produced
by beads embedded in 3D collagen gels. Individual T-cells exhibited a binary response to
isolated attractant sources, migrating highly directionally or ignoring the gradient completely; the
fraction of responding cells correlated with chemokine receptor occupancy induced by the
gradient. In sustained gradients eliciting low receptor desensitization, attracted T-cells or
dendritic cells swarmed around isolated ASCs for hours. With increasing ASC density,
overlapping gradients and high attractant concentrations caused a transition from local swarming
to transient "hopping" of cells bead to bead. Thus, diverse migration responses observed in vivo
may be determined by chemoattractant source density and secretion rate, which govern receptor
occupancy patterns in nearby cells.
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Chapter 5 Conclusion and future work
5.1 Summary of results
Chemoattractant gradients play important roles in the realm of embryonic development and
organogenesis, and tissue engineering, etc. [40]. Especially in the normal function of immune
system, leukocyte trafficking is indispensable, from lymphocyte homeostasis to mounting
efficient immune response against infection [1, 2, 32]. Studying the role of chemoattractant
gradients developed around single source cells on controlling chemotaxis of receiving cells
would not only greatly help understanding the basic mechanism of cell chemotaxis but also
would shed light on modulating chemoattractant gradients in therapeutic applications.
In this thesis, we have first applied a mathematical model to understand the key
characteristics of chemoattractant gradients secreted from single source cells. In the model an
isolated cell with diameter of 20 pm is assumed to secrete chemoattractant in a uniform omni-
directional manner at physiological rates of 0.01-1 pg/hr/cell. During the transport process of
chemoattractants, we considered the diffusion of soluble form, binding to matrix and degradation
by proteolytic enzymes. Based on the calculated chemoattractant concentration gradients, we
predicted the chemokine receptor engagement gradients for receiving cells. By comparing with
the threshold for receptor engagement gradients, ~10 ligand-engaged receptor difference between
front and back of responding cells [102], we could estimate the maximum stimulation distance to
be effective in triggering chemotaxis of responding cells for chemoattractant gradients developed
around single source cells, -150 pm. This characteristic maximum stimulation distance is a
function of multiple parameters including secretion rate of the source cell, diffusion constant of
chemoattractant, interaction with matrix, degradation or clearance of chemoattractant in the
tissues, and the density of source cells. We analyzed the concentration gradient and receptor
engagement gradients for CCL21 and CCL19, two ligands for the same chemokine receptor
CCR7 and playing critical roles in recruiting mature dendritic cells from infection site to
lymphatics and T-cell homeostasis, as model chemoattractants.
By understanding the gradients developed around single cells, we have noticed the
limitation of current in vitro chemotaxis assays that no defined gradients have been created to
simulate this gradients profile around single cells, i.e. "point" sources. We developed artificial
secreting cells (ASCs) to mimic real chemoattractant secreting cells, using cell-sized
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polysaccharide based hydrogel microspheres releasing chemoattractant in a controlled manner.
These alginate hydrogel microspheres, ~30 pm in size, were crosslinked with Ca" between
gluronic acid units on alginate backbones and provided a natural and bioactive environment for
chemokines [89]. The chemokines could be loaded to these alginate microspheres by soaking
them in concentrated chemokine solutions and released in a reversible manner. This strategy
was shown as a general strategy for several chemokines, such as CCL21, CCL19, CXCL10 and
CXCL12 in this thesis. The loading and release properties of individual chemokines were highly
correlated with the average charge density on protein surface. We have also demonstrated that
the controlled gradients created by artificial secreting cells were similar to the modeled gradients
developed around single source cell.
Further we used 3D collagen hydrogel embedded with artificial secreting cells as an in
vitro to investigate single human T-cell migration dynamics to CCL21 and CCL19 artificial
secreting cells. Individual T-cells exhibited a binary response to isolated attractant sources,
migrating highly directionally or ignoring the gradient completely; the fraction of responding
cells correlated with chemokine receptor occupancy induced by the gradient. In sustained
gradients eliciting low receptor desensitization, attracted T-cells or dendritic cells swarmed
around isolated ASCs for hours. With increasing ASC density, overlapping gradients and high
attractant concentrations caused a transition from local swarming to transient "hopping" of cells
bead to bead. Thus, diverse migration responses observed in vivo may be determined by
chemoattractant source density and secretion rate, which govern receptor occupancy patterns in
nearby cells.
5.2 Future work
In this thesis, we have showed that the reductionist in vitro model was used to investigate
human T-cell chemotaxis behaviors by correlating the receptor engagement gradient with
phonotypical migration behaviors, such as instantaneous chemotactic index, approach angle,
migration path, etc. Further this system can be used for studying the downstream signaling
pathway of chemotaxis with the use of fluorescently tagged signal proteins by creating defined
and physiological chemoattractant gradients from "point" source. It would be interesting to
understand calcium flux, chemokine receptor localization, intracellular key players (such as
P13K, etc.) during cell chemotaxis, and correlate phenotypic migration behaviors with these
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signaling path ways. Chemokine receptors with fluorescent protein tags can be transfected and
stably expressed on T-cell lines and thus chemokine receptor localization during chemotaxis can
be probed [187]. T-cells can be fluorescently labeled with calcium sensitive dye, such as Fura-2,
and thus calcium flux can be monitored during cell chemotaxis. The advantage of this system
would lie in providing well-defined physiological gradients to correlate with signaling pathways
to deeply understand how cells make chemotactic decisions.
Since this strategy to make artificial secreting cells can be generalized to multiple
chemoattractants and these artificial secreting cells can provide sustainable well-defined
gradients rather than transient gradients, this system can be used to study slow cell chemotaxis,
such as fibroblasts. The slow migrating cells usually have speed of even less than 0.5 pm/min
[188] and usually take a few hours to observe significant movement. This system definitely
provides advantage over traditional in vitro chemotaxis assays, like pipette assay. To understand
both the phenotypic migration behaviors and underlying signaling pathways between slow
migrating and rapid migrating cells would provide fundamental insight in cell migration.
This system also provides the possibility to be used in immunotherapy and vaccine delivery
by attracting target effector cells to desired tissue sites. The alginate hydrogel has low
immunogenicity itself and has been extensively used in multiple in vivo applications [138, 139,
149]. More generally, attractants involved in developmental, wound healing, and tissue
regeneration processes could be delivered using this approach to engineer chemotaxis of many
cell types in vitro and in vivo. It would be interesting to use this chemokine delivery system as
adjuvant materials in a biopsy setting to attract rare expressed cells in tissue using specific
chemoattractants.
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